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Summary 
Summary 
Here it is reported a population genetic study of more than 430 environmental 
strains of P. aeruginosa, mostly from river systems in Northern Germany but also 
from worldwide distributed sampling places. We identify several genetic lineages, 
of which one is apparently of a predominantly environmental nature. We observe 
a non-random distribution in environmental habitats and we identified ecological 
criteria which may be explanatory for this. The results suggest that different 
selective pressures aid to drive the cladogenic split of evolutionary lineages 
within P. aeruginosa. This study shifts the clinically motivated but from a global 
perspective rather narrow focus of P. aeruginosa as an opportunistic pathogen to 
its rather true nature as an environmental organism.  
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1. Introduction 
 
1.1. Short history summary on theory of evolution and evolution driving forces 
At the beginning of the 19th century, a French naturalist named Jean Baptiste Pierre 
Antoine de Monet, Chevalier de Lamarck proposed a full-blown theory of evolution, one of 
the earliest theories. There, an alchemical complexifying force drove organisms up a 
ladder of complexity, and a second environmental force adapted them to local 
environments through use and disuse of characteristics, differentiating them from other 
organisms (Gould, 2002). Charles Darwin expressed in 1859 in his “On the Origin of 
Species” a different mechanism for the modus of species evolution. The entire diversity of 
life forms “from so simple a beginning” was depicted to originate, probably, from the 
common ancestor (Darwin, 1859). However, Darwin’s ideas lacked the vital basis of 
genetics, as at this days Mendel’s works on the mechanisms of heredity appeared 
unnoticed. Only in the first third of 20th century Mendel’s laws were rediscovered and the 
next stepping stone was put to the establishment of the genetic basis of evolution and 
hence, population genetics started its development. Theoretical and experimental works in 
genetics consequently brought new light into the understanding of evolution, and the so-
called Modern Synthesis of evolutionary biology arose (Dobzhansky, 1937; Huxley, 1942; 
Mayr, 1944; Simpson, 1944). Nowadays evolutionary biology faces new challenges and 
perspectives for the next contemplative breakthrough stepping stone (Rose & Oakley, 
2007). The modern stage could be referred to as Evolutionary Biology in the Light of 
Genomics by the analogy to the Modern Synthesis described as Darwinism in the Light of 
Genetics (Koonin, 2009). 
Evolution is regarded as the change of phenotypes in the course of generations of 
populations (Mayr, 1997). Microevolution is that part of evolutionary science which deals 
with changes at the level of species or below, whereas macroevolution deals with the 
changes that finally lead to the characteristics of taxa higher than species. The current 
definition and meaning of this term was established in the third decade of the last century 
with the publication of “Variabilität und Variation” by Yuri Filipchenko (Filipchenko, 1927). 
Microevolutionary processes may be categorized in two ways: anagenesis and 
cladogenesis. Anagenesis is regarded as the phyletic change of the structure of a single 
lineage over time, without the emergence of another, novel, lineage. Cladogenesis, in 
contrast, is the splitting event of one genetic lineage into two or more genetically different 
lineages. In this way two or more new forms (species) evolve from one common ancestor. 
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Both of these processes are governed and driven by the population genetic forces of 
mutation, recombination, natural selection and genetic drift (Hartl & and Clark, 2007; 
Lynch, 2007a; Lynch, 2007b) 
Natural selection is the process by which an organism that displays favorable 
characteristics has a higher probability to leave descendants and pass on its genes than 
other organisms not representing this characteristic. Natural selection acts on the 
phenotype (Mayr, 1997), but this phenotype needs to be inheritable, as the genetical 
material is the baggage that descendants get. Thus, the phenotype is being selected and 
natural selection removes variability from the group. 
Mutation is the change in the DNA of the organism. Mutations can be classified as 
highly deleterious, weakly deleterious, nearly neutral, neutral, weakly advantageous, 
strongly advantageous (Kimura, 1983). Irrespectively, mutation is a major source of 
variation on which selection then can act and, thus, lead to adaptation [the process by 
which a population becomes better suited to its environment (Orr, 2005)]. The critical point 
for the molecular evolution discussions is the fixation probability of the given mutation. 
According to the selection theory (neo-Darwinism), most of the occurring mutations are 
deleterious, and only few are advantageous. Those advantageous mutations are selected 
and, thus, are being rapidly fixed in the population (i.e., are present in more than 95% of all 
individuals). Selection here is the only force that contributes to the mutation’s fixation in the 
population. Thus, neo-Darwinism regards the majority of genetic diversity in a population 
to be the result of adaptive process. The neutral theory (Kimura, 1968) assumes that 
considerable quota of the mutations are neutral, only few are advantageous, and the rest 
of the mutations are deleterious. Deleterious mutations are removed from the population, 
while neutral mutations are fixed in the population by genetic drift, which is the impact of 
pure chance. According to the theory, genetic drift and selection are the forces that 
influence mutations’ fixation depending on the size of population. Drift mostly influences 
small populations and is less strong in large populations, whereas selection is weak in 
small populations but strong in large populations (Hartl & and Clark, 2007). This means 
that deleterious or slightly deleterious mutations are selected against in big populations, 
whereas advantageous mutations become fixed. In contrast, in small populations the 
power of selection is substantially reduced, which enables also slightly deleterious (near-
neutral) mutations to become fixed. The Neutral Theory does not neglect the action of 
selection; however, the Neutral Theory states that the majority of molecular genetic 
diversity in a population is of neutral or near-neutral character, but not of adaptive value 
(Ohta, 1973). 
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Recombination is the exchange of genetic material between organisms (Ochman et al., 
2000). Bacteria can exchange genetic material via several mechanisms: natural 
transformation, conjugation and transduction (Thomas & Nielsen, 2005). Natural 
transformation is the process of the uptake of free DNA from the environment and its 
heritable incorporation into the genome by naturally competent bacteria. Conjugation is 
possible when conjugative plasmids or transposons mediate formation of a pilus which 
allows a physical contact between the recipient and donor cells. This way the recipient cell 
receives the donor chromosomal DNA. Transduction is the process which is possible only 
via interaction of bacteriophage and bacterial cell, when phage while infecting new cell 
releases DNA into the new host (Claverys et al., 2000; Dubnau, 1999; Matic et al., 1996). 
Recombination can only be successful if the number of circumstances are sufficed. Those 
include: availability of the donor DNA to the recipient; the actual process of the uptake of 
the donor DNA by the recipient cell; escape from the recipient’s restriction enzymes; 
formation of a donor-recipient heteroduplex DNA molecule; escape of the heteroduplex 
from the host mismatch repair system; and functionality of the donor gene product in the 
new genetic background (Majewski, 2001). Recombination potential differs dramatically 
within bacteria: from highly panmictic Helicobacter pylori to highly clonal Buchnera (Falush 
et al., 2001; Vos & Didelot, 2009), consequently its influence on the microevolution 
process differs from population to population. For example, in naturally transformable large 
populations, a single nucleotide change is around 50 times more seemingly to occur 
through recombination than through mutation (Feil et al., 2000; Guttman & Dykhuizen, 
1994). Thus, recombination (parasexuality) is another major population genetic force that 
increases variability in prokaryotes. Besides mere increase in variability, when the 
recombination rate strongly exceeds the mutation rate, recombination has a cohesive 
effect, which may avoid or at least hinder the cladogenic split of lineages. 
The numerous combinations in which these four forces can interact at varying 
quantities to determine the fate of a population can result in different evolutionary styles 
according to which organismic lineages may evolve (Cohan & Perry, 2007). 
Microevolution of different species has been under the close interest for quite a while, 
and, thus, specific tendencies in species evolution were recovered for some bacteria. In 
the discussion about species microevolution and speciation process, it is necessary to 
clarify the term “species”. Thus, before discussing any concrete examples of such bacterial 
species, it is necessary to take a closer look on what, actually, is a species from the point 
of view of microbiologists and taxonomists, which concepts and ideas exist and which 
driving force(s) in which theory is belived to have higher impact. 
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1.2. Bacterial species and speciation driving forces 
What are bacterial species? This question is far from simple and straightforward to be 
answered; it evokes a lot of discussions and disagreements among microbiologists, same 
as the issue of speciation and its driving forces. Below different approaches and concepts 
are described. 
 
1.2.1. Phenetic species concept 
Currently, a polyphasic (phenetic) species concept is being used by microbial 
taxonomists and systematists. Polyphasic taxonomy arose more than three decades ago, 
and it aims to integrate different kinds of data (phenotypic, genotypic, and phylogenetic) on 
microorganisms (Colwell, 1970; Vandamme et al., 1996). Nowadays some concrete rules 
for the species affiliation exist: the species is estimated as a basic unit of taxonomy 
(Wayne et al., 1987) and is “a group of strains, including the type strain, sharing 70% or 
greater DNA-DNA relatedness with 58°C or less DTm (DTm is the difference in the melting 
temperatures in degrees Celsius between the homologous and heterologous hybrids 
formed under standard conditions)” (Wayne et al., 1987). Also, 16S rRNA sequence 
comparison might serve as the first indication that a new species has been isolated (less 
than 97% sequence similarity over full pairwise comparisons) (Tindall et al., 2009). 
According to the phenetic concept, phenotypic and chemotaxonomic characteristics of 
the bacteria should be also determined and must be in agreement with the results of the 
genomic comparison. A type strain must be denominated, and henceforth this strain is 
used as a reference specimen and name bearer (Staley & Krieg, 1984). In the current 
genome era propositions of new, several genome sequence based algorithms for the 
species affiliation emerge, which are meant to replace the laboratory work of DNA-DNA 
hybridization (Auch et al., 2010; Richter & Rossello-Mora, 2009). In principle, values for 
the similarity of genome sequences are obtained by different algorithms and are calibrated 
to the 70% DNA-DNA hybridization threshold value for species delineation (Auch et al., 
2010; Konstantinidis & Tiedje, 2005; Richter & Rossello-Mora, 2009). 
The polyphasic microbiological species concept partially matches to the eukaryotic 
species concepts. It is also phenetic, phylogenetic and genotypic. Phenetic in the way that 
it is numeric and attempts to classify organism basing on their overall similarity: on their 
morphological or other observable characteristics (though some of these traits are not 
necessarily universal for the whole taxon). It is phylogenetic in the sense that all the 
members of the group are closely related to each other and are descendants of the 
common ancestor. And, finally, polyphasic concept is based on the genotypic cluster 
definition (Mallet, 1995). There are definite numerical borders for genome comparisons, 
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which should guarantee allied interrelation of the members of the cluster (Rossello-Mora & 
Amann, 2001). 
The polyphasic concept undoubtfully has a number of advantages; it is pragmatic and 
can be applicated to nearly all prokaryotes. The prokaryotic world is much more diverse 
than the eukaryotic world (Whitman et al., 1998). Thus, the polyphasic approach is 
successfully solving the problem of the bacterial species affiliation, dealing with the 
enormous amount of diversity (Tindall et al., 2009). In order to settle common rules for 
validly publishing the names of any new species, the Bacteriological Code of 
Nomenclature was arranged (Lapage et al., 1992; Tindall et al., 2009). 
However, the current taxonomical approach is far from being perfect. It resulted in 
groups (species) that vary tremendously in their genetics, physiology and ecology (Cohan 
& Perry, 2007; Staley, 2006). Consequently, such situation led to numerous arguments 
and discussions between bacteriologists. Moreover, arguments start already at the point of 
what bacterial species should be understood as. Whether species should just represent 
phenotypically and genetically similar group of organisms? Or should it cluster together 
individuals with specific genomic/genetic, ecological, phylogenetic and evolutionary traits? 
In principle, microbiologists with an evolutionary but not a systematist’s background, 
question the validity of the current taxonomic practice to capture microbial diversity from a 
truly biological perspective. Therefore, researchers have provided and continue to provide 
multitudinous attempts to propose the most appropriate and functioning way of species 
identification and affiliation. 
 
1.2.2. The Ecotype concept 
Frederick M. Cohan, Wesleyan University, CT, is one of the evolutionary biologists who 
efforts to set species definition and traits of its evolution. From his perspective, species 
determination in taxonomy cannot be separated from the evolution and ecology. Together 
with colleagues he developed a concept based on bacterial taxa, which are referred to as 
“ecotypes” (Cohan, 2001; Cohan, 2002; Cohan & Perry, 2007; Cohan & Koeppel, 2008; 
Koeppel et al., 2008). In this concept authors combine ecological and evolutionary theory 
for the identification of the fundamental units of bacterial lineages (ecotype) via attempts to 
identify specific DNA sequence clusters. Ecotype is believed to be the group of bacteria 
that are ecologically similar to one another, so similar that genetic diversity within the 
ecotype is limited by a cohesive force, either periodic selection or genetic drift, or both 
(Cohan & Koeppel, 2008). It was demonstrated that commonly recognized nowadays 
named species are often in fact mixture of different ecotypes. Every each of which express 
their own properties of a species. 
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In order to get an experimental support for such a framework, ecotypes within the 
natural community of Bacillus clades sampled from the ‘‘Evolution Canyons’’ in Israel and 
Death Valley (USA) (Connor et al., 2010; Koeppel et al., 2008) were identified. For this, a 
sequence-based approach (‘‘Ecotype Simulation’’) was introduced to model the 
evolutionary dynamics of bacterial populations. As a result of the Ecotype Simulation, 
several ecotypes within the same named species were identified, each representing 
ecologically distinct lineage with specialization to different canyon slopes with the different 
solar exposure. 
This approach is claimed to provide a lacking natural foundation for microbial 
systematics and ecology. To systematize and schematize the ecotype concept approach 
in agreement with the phenetic concept, it was suggested to add an “ecovar” epithet to the 
species binomial whenever several ecotypes are recognized within the admitted spectrum 
of a currently established species. Furthermore, in those cases where an ecotype is 
discovered to be outside the phylogenetic range of the species, such an ecotype should 
represent a new species (Koeppel et al., 2008). The conclusion was made that such two 
folded approach should enrich bacterial systematics with ecologically significant, but 
previously ignored groups, while still respecting the stability of taxon names. Moreover, 
this approach would not violate any rules of the Bacteriological Code. 
Some bacteriologists do welcome the incorporation of “evolutionary thinking” in the 
prokaryotic taxonomy at the level of species. Several articles were issued where the 
debate that “microbiologists need, in general, take a more natural view of the organisms 
they study” was raised (Ward, 1998; Ward et al., 1998; Ward et al., 2006), with the claim 
that it is time already to start paying attention to the evolutionary and ecological patterns of 
the species, and that bringing a more natural view to the prokaryotic species concept is of 
a the vital necessity. After study of the microbial biodiversity of the hot spring 
cyanobacterial mat communities by 16S rRNA sequences, the conclusion was drawn that 
in particular this method might be inappropriate for defining all ecologically specialized 
populations, as 16S rRNA sequences might be excessively conserved to succeed with 
such a goal (Ward et al., 1998). 
Another work dealing with the marine microbes’ communities attempt to identify and 
recover speciation driving forces of these bacteria (Polz et al., 2006). Genome analysis 
revealed some variations among studied bacterial genome from given populations. And, 
according to authors, these variations were persistent with the lifestyles of every each 
population. Some cluster formations were observed, the same as distinct patterns of 
different loci and genome regions, allowing to conclude that they might be a result of 
intricate interaction of homologous recombination and selection (Polz et al., 2006). In the 
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successive research that was provided with the use of the AdaptML [a maximum-
likelihood-based framework tool for studying both the sequence evolution and ecological 
history of a set of gene sequences (Hunt et al., 2008)] ecological differentiation of 
bacterioplankton and populations specific for seasons and life-styles (combinations of free-
living, particle, or zooplankton associations) were discovered (Fraser et al., 2009; Hunt et 
al., 2008). Though these populations were mostly consistent with the named species, 
ecologically different populations on distinct levels of phylogenetic differentiation were 
uncovered for Vibrio splendidus. Authors believe that such a founding might be an 
evidence for recent and perhaps still ongoing adaptive radiation. This way it appears as 
environmental specialization (natural selection) might be of an important interrelation, or 
even serve as a trigger for speciation among sympatric bacteria (Fraser et al., 2009; Hunt 
et al., 2008). 
 
1.2.3. Recombination as cohesive force in speciation 
Nevertheless, there are a lot of argues and disagreements with the ecotype approach 
in which cohesive and driving speciation forces in bacterial species microevolution are 
pointed out to be either periodic selection or genetic drift, or both. In some works the main 
cohesive force is pointed out to be recombination, while genetic drift is believed to have 
rather a splitting power (Feil & Spratt, 2001; Fraser et al., 2005; Fraser et al., 2007; 
Hanage et al., 2006a; Hanage et al., 2006b; Spratt & Maiden, 1999). While analyzing 
population structure of some pathogenic bacteria (which is believed to represent fairly all 
genetic diversity), the population structure and molecular characteristics of pathogens (i.e. 
Helicobacter pylori, Neisseria gonorrhoeae, Salmonella enterica and Neisseria 
meningitidis) was determined and the conclusion was made that simple evolution model 
that is based on neutral mutational drift, modulated by recombination is the most 
appropriate for the microevolution description of these bacteria (Fraser et al., 2005). 
Moreover, it was shown that the rate of the recombination has the strongest influence on 
the genetic discrepancy, and, thus, distinction should be made between clonal divergence 
and sexual speciation (Fraser et al., 2007). 
 
1.2.4. Geographical isolation driving evolutionary divergences (i.e. genetic drift) 
Another driving parameter for the species microevolution was suggested to be physical 
isolation of populations by their geographical separation (Whitaker, 2006). For example, in 
a detailed study of the island-like hot spring cyanobacterial communities some divergence 
was discovered and explained by geographical isolation (i.e. genetic drift) and was 
pronounced to influence the evolution of bacteria (Papke et al., 2003; Papke & Ward, 
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2004). Furthermore, after analysing the archaeon Sulfolobus by Multi Locus Sequence 
Typing (MLST) a similar conclusion was made: populations of hyperthermophilic 
organisms have recently diverged due to the geographical barriers, and even more, this 
relation was shown to be congruent on a global scale (Whitaker et al., 2003). Even more, 
when MLST analysis of the tick-borne bacterium Borrelia burgdorferi (the causative agent 
of Lyme borreliosis) was performed, North American and European populations were 
revealed to be genetically different, this findings was also interpreted to be a result of 
geographical isolation (Margos et al., 2008). 
 
1.2.5. Do species exist at all? 
Finally, one of the most discrete species concepts is the concept of “no species”. The 
main idea of this concept is that there is no such a thing as “species” in the microbial world 
(Bapteste et al., 2009; Doolittle & Papke, 2006; Doolittle, 2008; Doolittle, 2009; Doolittle & 
Zhaxybayeva, 2009). Taxonomists, systematics and microbiologist according to this theory 
are dealing with the “man-made” names, in the nature there are no (and should not be) 
essential reasons for appearing any groups of individuals possessing coherent genetic and 
phenotypic features that would allow them to fit in the definition of “species” (Doolittle & 
Papke, 2006; Doolittle, 2008; Doolittle, 2009; Doolittle & Zhaxybayeva, 2009). Prokaryotic 
evolution and the tree of life are two different things, and they need to be treated such, and 
not extrapolating from macroscopic life to prokaryotes (Bapteste et al., 2009). Lateral gene 
transfer and recombination are the processes that make it nearly impossible to come out 
with single species concept model. Any genome clusters that have been studied and 
described so far, might be explain by the pure chance or, rather by the limitations in 
culturing methods, samplings and/or used methods of genome diversity studies. Accepting 
the whole idea of natural species existence for granted, is the mistake that many of the 
researchers make and, therefore, they do accept any level of clustering to be another 
evidence of subsistence of “genuine” species (Doolittle, 2008; Doolittle, 2009; Doolittle & 
Zhaxybayeva, 2009). However, Doolittle and colleagues do not fully repel taxonomic 
practice (Dipippo et al., 2009), as humans, perhaps as result of their evolved psychology, 
will always need to make classifications, as scientists, however, there is no need to believe 
in taxonomic classifications (Doolittle, 2009). 
 
1.3. Population structure and style of microevolution of bacterial species 
Microevolution of different bacteria has been under the high interest by the 
microbiological community for quite a while already and some meaningful information on 
this subjected was produced. Also, some attempts to analyze and classify the 
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accumulated insights were made. One of such efforts resulted in the detailed overview and 
graphical description of possible diversity of the evolutionary models (Cohan & Perry, 
2007; Ward et al., 2008). These models accounts for various ways in which diversity might 
be introduced into the population (i.e. via mutation, recombination, etc.), and how the 
inhabited niche might influence this diversity (i.e. via genetic drift, natural selection, 
geographic isolation, etc.). Among listed are following models: stable ecotype, genotype + 
boeing, genetic drift model, speedy speciation, species-less, nano-niche model, recurrent 
niche-invasion, cohesive recombination model and animal-like model. 
Stable Ecotype model. According to this model, natural selection is the power that 
provides cohesion to the bacterial cluster. Within species diversity is proposed to be 
supplied by power of mutation and recombination. Ecotypes (ecologically distinct 
populations) hold different ecological niches, and are adapted to the occupied niche. 
Rather weak recombination do not allow big within-population diversity, and periodic 
selection events furthermore are able to purge the population by assuring that the most 
fitted in this environmental conditions mutant or recombinant sweeps the whole population. 
When one population invades a new ecological niche, separation process starts by natural 
selection force. As a result, two different phylogenetic lineages evolve, each representing 
ecologically different population (Cohan & Perry, 2007; Ward et al., 2008). 
Examples of microbial groups, possessing such a microevolution style, are 
Mycobacterium tuberculosis (Smith et al., 2006b) and Bacillus simplex (Sikorski & Nevo, 
2005). 
Geotype-plus-Boeing model. In this model, cladogenesis is triggered by the physical 
(geographical) isolation and within population diversity is provided by accumulation of the 
neutral mutations.  
Geographical isolation in the modern world is not as stable as it was previously. 
Microbes are transferred from place to place, from country to country and from the 
continent to continent together with people. Therefore, sometimes several bacterial 
distinguished groups can be found within one ecotype at one place, as can be observed 
with the bacterium Yersinia pestis (Achtman et al., 2004). Thus, the hypothesis is that 
before the time of speedy human transportation, geographically separated and isolated 
populations of the same ecotype might have diverged into secluded clusters. With the 
advent of rapid and worldwide transportation systems, the endemic geotypes within single 
ecotypes start to merge geographically. As a result, separate populations, which 
nevertheless belong to the same ecotype, can now be observed in the same geographical 
location. So, the example of microbial group for the Genotype + Boeing model is Yersinia 
pestis (Achtman et al., 2004). 
1. Introduction 
 11
Genetic drift model. This model mostly likely is represented in obligate pathogenic and 
endosymbiotic bacteria. The size of the population is rather small and limited, therefore, 
random genetic drift have very high impact and allow fixating allelic variants, resulting in 
subclusters of closely related individuals. Bacteria illustrating genetic drift model might be 
Buchnera (Herbeck et al., 2003; Moran & Mira, 2001; Moran et al., 2002). 
Cohesive recombination. In the bacteria, in which genetic recombination rates are very 
high, recombination serves as cohesive force. Such a situation might be the case, when 
repetitive recombination events are observed within and between several closely related 
populations.
Helicobacter pylori can serve as a bacterial example of such a speciation model 
(Falush et al., 2001). 
Species-less model. In a rapidly changing environment new populations arise and 
extinct also very fast. Therefore, the genetic diversity within the species must not be 
limited into the specific habitat conditions, no evolution force must serve as a cohesive; 
vice versa, every each mutant or recombinant might serve as a founder for the new, 
rapidly inventing and extincting, species. Thus, the only cause of homogeneity within the 
cluster is the young age of closely related populations (species). Species-less model is 
proposed for being an appropriate in such situations. 
Recurrent niche invasion. This model is an appropriate one in the species that 
iteratively gain or loose their specific niche adaptations (like easygoing gain or loss of a 
plasmid) and by this might gain adaptations for different ecological niche. In the lineage it 
results in repeated float from niche to niche, such a trend means that every population is 
not an irreversibly separate lineage, and might never become a separate cluster. 
The best way to explain this model of speciation in details is by giving an example of a 
bacterium that performs it. Bacillus thuringiensis lineages can contain “alternative crystal 
toxin” plasmids, every of which is able to kill a different order of insect (Rasko et al., 2007). 
This lineage while loosing one crystal toxin plasmid and then getting another, transfers 
from one ecological niche to another. If such situation appears to be frequent, then this 
lineage is not inconvertible separate sequence cluster, and might never become such. 
Another organism that supposedly examples this model of microevolution is Rhizobium 
(Mutch & Young, 2004). 
Nano-niche model. In this model several lineages within single species exist. Every 
each of these lineages is adapted in a very slight way to their own nano-niche, within a 
single macrohabitat, they even might have their own periodic selection events [a 
‘speciation-quashing’ event (Cohan & Perry, 2007)]. Still, one adapted lineage might 
outcompete and extinct other ecological lineages. These subgroups are not necessarily 
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inconvertibly separated; they rather do not have enough time to diverge into separate 
sequence clusters. This is exactly the behavior that possess Vibrio splendidus in its 
adaptation to the small particles in the marine water column (Thompson et al., 2005). 
 
1.4. Introduction into Pseudomonas aeruginosa 
The first one to mention this bacterium in literature was Schroeter in 1872, in his 
publication it was called Bacterium aeruginosum (Schroeter, 1872). Since that time the 
name was changed several times, until the current name appeared and was validly 
published (Skerman et al., 1980). Since the isolation, a lot of different information was 
gathered on its physiology, genetics, ecology and phylogeny. 
It is a member of the Gammaproteobacteria class of Bacteria. Phylogenetically and 
taxonomically the species belongs to the family Pseudomonadaceae, which includes 12 
species, with Pseudomonas as type species. The genus Pseudomonas consists of 188 
species (Euzeby, 1997) and P. aeruginosa is the type species for this group (Olsen et al., 
1994). 
Physiological characteristics of the P. aeruginosa are the following: it is a Gram-
negative aerobic rod measuring 0.5 to 0.8 µm by 1.5 to 3.0 µm. Furthermore, it secretes 
different pigments like pyocyanin (blue-green), fluorescein (yellow-green and fluorescent), 
and pyorubin (red-brown) (Etymology: L. fem. adj. aeruginosa, full of copper rust, verdigris, 
hence green.). Preliminary it can be identified by its specific odor in vitro and by the blue-
greenish color of the fluorescent producing colonies. The optimum growth temperature is 
37°C; maximum temperature of growth is 42°C. Usually, the strains are motile by the 
means of a single polar flagellum. 
The genome size of P. aeruginosa ranges from around 5.2 Mb (Hector & Johnson, 
1990) till 6.3 Mb (Stover et al., 2000a). It consists of a conserved core and a variable 
accessory part. The genetic elements are non-randomly distributed across the genome 
(Wiehlmann et al., 2007). At the moment, seven genome sequenced strains (all are from 
clinical origin) are publicly available in the databases (http://img.jgi.doe.gov/cgi-
bin/pub/main.cgi; status May 2010). 
Ecologically, P. aeruginosa is widespread in natural habitats, and can be isolated from 
the multiple environmental niches, such as water, soil, plants, animals and humans 
(Goldberg & Pier, 2000). P. aeruginosa is also an important clinical agent, as it is an 
opportunistic pathogen that causes wide range of acute and chronic injures and diseases 
of plants, animals and, very widely, humans (Chugani & Greenberg, 2007). 
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1.4.1. The distribution of P. aeruginosa in the environmental habitats 
P. aeruginosa is a pervasive bacterium which invades a wide range of ecologically 
different habitats all over the world. It was widely reported to be isolated from different 
water sources: river water (Pirnay et al., 2005), sea water (Kimata et al., 2004) and 
opened ocean (Khan et al., 2007; Khan et al., 2008; Mena & Gerba, 2009). Also, P. 
aeruginosa is quite common in animals (Ozaki et al., 1990) and animal feces (isolation by 
M. Vives-Flórez from the horse stables, personal communication) and soil and vegetable 
material (Green et al., 1974). Besides these rather common habitats, P. aeruginosa is able 
to thrive also in extreme habitats such as sodium dodecyl sulfate (SDS) (Hagelueken et 
al., 2006). 
High ecological value at least for some strains of this bacterium were also reported 
(Bano & Musarrat, 2003; Hasanuzzaman et al., 2004; Szoboszlay et al., 2003). Some 
strains were proven to be good oil degraders (Hasanuzzaman et al., 2004; Szoboszlay et 
al., 2003). Other representatives of the P. aeruginosa were suggested to act as plant-
growth promoting and biocontrolling rhizobacteria (Anjaiah et al., 2003; Bano & Musarrat, 
2003). Moreover, it produces glycolipidic surface-active molecules (rhamnolipids) which 
have potential wide-range biotechnological applications (Pham et al., 2004; Soberón-
Chávez et al., 2005). 
 
1.4.2. The clinical significance of P. aeruginosa 
P. aeruginosa is able to cause a large set of different infections, both acute and 
chronic; it can invade any part of the body (http://emedicine.medscape.com/article/226748-
overview; status 22 June 2010). It commonly infects the respiratory tract of 
immunocompromised patients and people with the cystic fibrosis disease (CF). In 
individuals, abusing intravenous drugs, P. aeruginosa might infect native heart valves 
(Bicanic & Eykyn, 2002). Invading central nervous system P. aeruginosa causes 
meningitis and brain abscess (Davidson et al., 1982). Patients with uncontrolled diabetes 
are in a group risk for getting chronic otitis media; furthermore, extension of this otitis can 
result in osteomyelitis, and, more dangerously, can create cranial nerve palsies (Sander, 
2001). Eye-associated infections result in bacterial keratitis and scleral abscess (Hobden 
et al., 1999). P. aeruginosa is also able to involve in vertebral column, pelvis, and 
sternoclavicular joint, causing vertebral osteomyelitis (Watanakunakorn, 1975). 
Pseudomonal urinary tract infections are mostly hospital-acquired and typically appear 
after catheterization, instrumentation, or surgery (Shigemura et al., 2006). If patients 
suffering from neutropenia acquire P. aerugionosa, typhlitis is most likely to be developed 
(http://emedicine.medscape.com/article/226748-overview; status 22 June 2010). And, 
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finally, P. aeruginosa is one of the “curses” of the burn units where it is one of the most 
frequent source of burn wound sepsis (Baltch, 1994). 
One of the biggest problems in curing infections associated with P. aerugionosa is that 
this bacterium often prospers in clinical environments. There are multiple reports of 
detecting multi-resistant strains of P. aeruginosa from hospital floors, bed rails, sinks and 
from the hands of medical personnel [ i.e. (Altoparlak et al., 2005; Chitkara & Feierabend, 
1981; Hsueh et al., 1998)]. Due to the transfer from patient to patient, multi-drug resistant 
clones can remain in hospitals for many years (Hsueh et al., 1998), and, thus, it is one of 
the major nosocomial pathogens which attribute to the high percentage of patient mortality 
and morbidity (Altoparlak et al., 2005). 
 
1.5. Population structure of P. aeruginosa 
Most population genetic studies have been performed mainly under clinical 
perspectives (Pirnay et al., 2002; Pirnay et al., 2009; Rakhimova et al., 2009; Wiehlmann 
et al., 2007). Analysis of the genome linkage revealed that the recombination rate varies 
considerably in relation to the chromosomal location (Romling et al., 1995) and genomic 
regions, encoding housekeeping, provide low rates of recombination, whereas loci, 
encoding accessory genes, have higher rates of recombination and, thus, might be 
subjected to the comparable higher selection rates then housekeeping genes (Romling et 
al., 1995). Furthermore, the apparent consensus in the literature is that P. aeruginosa has 
a non-clonal epidemic population structure (Curran et al., 2004; Denamur et al., 1993; 
Picard et al., 1994; Pirnay et al., 2002; Pirnay et al., 2009). Epidemic structure assumes 
the existence of highly successful epidemic clones or clonal complexes, and indeed, 
several of these epidemic clones could be identified, such as the famous clone C or the 
clinical MDR serotype O:12 lineage  (Giammanco et al., 1985; Pirnay et al., 2009; Watine, 
1999). 
It is frequently stated that there is no difference between P. aeruginosa strains from 
different environmental or clinical habitats (Alonso et al., 1999; Foght et al., 1996; Kiewitz 
& Tummler, 2000; Morales et al., 2004; Ruimy et al., 2001). However, such notion appears 
to be questionable already in the light of the widely accepted observation that P. 
aeruginosa strains, once they have been occupied into a clinical habitat such as the 
human body, readily evolve in the due course by genetic changes in order to 
microevolutionary adapt to the characteristics of the human body (Lee et al., 2006; Smith 
et al., 2006a). Mutated factors include the loss of O-antigen components of the 
lipopolysaccharide (LPS), loss of twitching motility, loss of pyoverdine production, loss of 
secreted protease activities (including elastase), and reduced biofilm formation (Smith et 
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al., 2006a). Changes of other genes required for pathogenicity are not possible to follow, 
as virulence in P. aeruginosa is proposed to be both multifactorial and combinatorial, 
genes that might be responsible for pathogenicity in one strain, are “neither required for, 
nor predictive of virulence in other strains” (Lee et al., 2006). 
 
1.6. Phenotypic characterization of P. aeruginosa 
Little is known about the wide spectrum phenotypical characterization of environmental 
isolates of P. aeruginosa. Clinical isolates have been always under close attention, thus, 
there are some data on the physiological and phenotypical profile changes of the clinical 
strains of P. aeruginosa. Most common changes are the ones that are associated with its 
virulence in acute infections. Alterations include conversion to mucoidy, loss of flagella or 
pilus effected motility types, loss of serotype-specific antigenicity, and advent of the 
antibiotic multiresistant strains (Barth & Pitt, 1995; Luzar & Montie, 1985; Luzar et al., 
1985; Makin & Beveridge, 1996; Pedersen et al., 1986a; Pedersen et al., 1986b; Sener et 
al., 2001). Possible explanation of physiological changes might be associated with the 
adaptation processes allowing bacteria to survive in the hostile surrounding of the lungs of 
CF patients (Drenkard & Ausubel, 2002; Mahenthiralingam et al., 1994; Mahenthiralingam 
& Speert, 1995). 
Motility. P. aeruginosa utilizes three ways of cellular motility: swimming, swarming and 
twitching; the choice for the movement type depends on the situation (Fraser & Hughes, 
1999). Swimming and swarming are guaranteed by flagella, twitching is being mediated by 
type IV pili. Planktonic P. aeruginosa residing in fluidic environments (river, sea, ocean, 
etc.), displays a swimming motility type. When cells are on semi-solid surfaces, or solid 
surfaces with the liquid layer, swarming is the type of performed movement, cells transfer 
to the hyperflagelated and elongated phenotype and start to move in a coordinated maner. 
Being on solid surfaces, P. aeruginosa cells, by means of pilus retraction and extension, 
move in a way called twitching motility. Twitching is necessary for infectivity and biofilm 
formation process (Beatson et al., 2002a; Beatson et al., 2002b; Fraser & Hughes, 1999; 
Leone I., 2008; Rashid & Kornberg, 2000). 
Biofilm formation. Biofilm is the form of bacterial communities which are adhered to a 
surface and it is believed that mostly bacteria are indwelled in the environment in this form 
(Costerton et al., 1995). It protects bacteria from hostile influences from the habitat, such 
as UV exposure, metal toxicity, acid exposure, dehydration and salinity, as well as 
infection challenges (i.e. phagocytosis, antibiotics and antimicrobial agents) (Stoodley et 
al., 2002). 
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In response to different signals, such as nutritional and/or oxygenic status of habitat, 
individual planktonic cells initiate interaction with surface and form intricate and highly 
structured bacterial communities which are termed biofilms (O'Toole & Kolter, 1998a; 
O'Toole & Kolter, 1998b; Pratt & Kolter, 1998; Wimpenny & Colasanti, 1997). Fully 
developed biofilms can perform different architectural and physical/chemical qualities 
(Costerton et al., 1995). Some cells of P. aeruginosa within such a biofilm were shown to 
behave differently from those that exist in planktonic form, providing different genes 
expression profile for some genes [i.e. algC gene required for the synthesis of extracellular 
polysaccharides (Davies et al., 1993; Davies & Geesey, 1995) and ampC gene which 
encodes for a beta-lactamase precursor (Bagge et al., 2004a; Bagge et al., 2004b)] and 
phenotypes, at least with the respect to the heightened antibiotic resistance (Hoyle BD, 
1991). Although it is believed that most (though not all) of the cells present in the biofilm 
reside in the stationary physical phase (Waite et al., 2005; Waite et al., 2006), it was 
shown that some adaptations are necessary for the, i.e., anaerobic oxidation and iron-
limitation stress (Hentzer M, 2003). 
Several factors are known to be needed and involved in the biofilm maintenance and 
development of P. aeruginosa, such as flagella, type IV pili and las-rhl quorum-sensing 
system (Davies et al., 1998; O'Toole & Kolter, 1998a; O'Toole & Kolter, 1998b). This 
model for P. aeruginosa biofilm formation, presenting involvement of flagella in 
attachment, the need for twitching ability (which is in P. aeruginosa type IV pili-driven 
motility) in microcolony formation and the following development of microcolonial 
structures, is generally accepted to be common for P. aeruginosa biofilm development 
(Costerton et al., 1999; O'Toole et al., 2000; Stoodley et al., 2002). 
Pyocyanin production. P. aeruginosa strains are able to produce two types of soluble 
pigments: pyoverdine, the fluorescent pigment and the blue pigment pyocyanin. Pyocyanin 
is produced by cells after the exponential phase of growth. This blue pigment is highly 
important for the P. aeruginosa due to the ability to provide antibiotic activity against a 
wide variety of bacteria (Baron & Rowe, 1981; Hassan & Fridovich, 1980; Schoental, 
1941), to the capacity to kill mammalian cells (Hassett et al., 1992) and to raise apoptosis 
level of human neutrophils (Hassett et al., 1992). Considering its biological activity, the 
intensive production of pyocyanin by clinical isolates of P. aeruginosa was detected 
consistently (Finnan et al., 2004; Fothergill et al., 2007; Reyes et al., 1981; Wilson et al., 
1988). 
Pyocyanin’s cytotoxicity is strongly linked to its ability to redox (reduction-oxidation 
reaction) cycle (Hassan & Fridovich, 1980). It accepts electrons directly from either NADH 
or NADPH and then, under aerobic conditions, it passes them further to O2, which leads to 
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the generation of the reactive oxygen species (ROS) superoxide (O2--) and hydrogen 
peroxide (H2O2) (Hassan & Fridovich, 1980). Furthermore, with the use of cellular reducing 
equivalents (e.g., NADH or NADPH), addition of pyocyanin to cells places them under 
increased oxidative stress (Hassan & Fridovich, 1980). 
Proteolytic activity. P. aeruginosa can secrete alkaline protease and two elastases, 
which have been distinguished as exoenzymes and virulence factors (Howe & Iglewski, 
1984; Kernacki et al., 1995; Kessler et al., 1993; Ohman et al., 1980; Twining et al., 1993). 
Proteases produced by P. aeruginosa were shown to be important for the establishment of 
an infection, as well as for the amount of damages caused by it (Baker, 1982; Nicas & 
Iglewski, 1985). Moreover, protease activity was demonstrated to play a role in tissue 
damaging and enhancement in virulence in different human infections, such as damaging 
respiratory epithelium of cystic fibrosis patients (Suter, 1994) and increased virulence of P. 
aeruginosa in burn patients (Pavlovskis & Wretlind, 1979). 
Survival in water. There are numerous reports existing on the survival of P. aeruginosa 
in water (Byrd et al., 1991; Favero et al., 1971; Kayser W. V. et al., 1975; Khan et al., 
2007; Legnani et al., 1999; Sjogren & Gibson, 1981). Different types of water were tested 
in these studies: drinking water, clinical distilled water, natural mineral water, lake water, 
etc. In spite the fact that reported survival periods varies quite substantially [from 95 days 
(Byrd et al., 1991) up to 5 years (Legnani et al., 1999)], the same conclusion was 
continuously made: P. aeruginosa cells are able to survive durably in different aquatic 
surroundings (Byrd et al., 1991; Favero et al., 1971; Kayser W. V. et al., 1975; Legnani et 
al., 1999; Sjogren & Gibson, 1981). 
Serotypes. P. aeruginosa is known to be serologically heterogeneous, the heat-stable 
lipopolysaccharide (LPS) component of the outer membrane determines the O-antigenic 
type and the core LPS components are conserved throughout the species (Chester et al., 
1973). Numerous serological typing schemes have been described for P. aeruginosa 
(Dayton et al., 1974; Fisher et al., 1969; Habs, 1957; Homma et al., 1971; Lanyi, 1966; 
Meitert, 1964; Sandvik, 1960; Verder & Evans, 1961) but only a few have been widely 
used (Fisher et al., 1969; Habs, 1957; Homma et al., 1971; Verder & Evans, 1961). All 
these schemas were not 100% comparable to each other and the necessity for the unitary 
system arose. Following such urge, the Subcommittee on Pseudomonadaceae and 
Related Organisms of the International Committee of Systematic Bacteriology of the 
International Association of Microbiological Societies (IATS) proposed seventeen O-
groups as the standards for serotyping P. aeruginosa (Liu et al., 1983). 
Though the serotype profile was thought to be a rather stable characteristic of P. 
aeruginosa strains, polyagglutination, autoagglutination and “no agglutination” phenomena 
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were shown to be quite frequent for clinical isolates, especially for strains that induced 
chronic infections (Hancock et al., 1983; Pitt et al., 1986). Polyagglutinating strains, are 
those that get agglutinated by more than one antiserum towards unrelated O-antigens; 
autoagglutinating strains are those that get self-agglutinated in the physiological saline in 
the absence of antiserum; and, finally, “no agglutination” phenomena is observed in strains 
that do not get agglutinated by any antiserum (Hancock et al., 1983). Independent reports 
have confirmed that these serologically atypical forms are antigen variants which are 
defective in their ability to synthesize O-specific side chains of LPS (Hancock et al., 1983; 
Pitt et al., 1986). 
Bacteriophages. Bacteriophages are the most frequent and ubiquitous biological 
entities in our world – they are everywhere: in the oceans, soil, deep sea vents, the water 
we drink, and the food we eat (Sulakvelidze & Kutter, 2005). Their total count is estimated 
to be in the range from 1030 to 1032 in total, and their essential role in every ecosystem (in 
which this ever was explored) was proved to lie in regulating the microbial balance 
(Sulakvelidze & Kutter, 2005). 
Lately, the increase in interest for bacteriophages’ studies can be observed. Such a 
expansion of this field of research is happening due to several reasons - microbiologists 
started to recognize phages’ ecological essence, their vital role in life’s origin and 
evolution, and their therapeutic potential (Ceyssens et al., 2009). The therapeutic potential 
of bacteriophages is becoming more and more promising and a vital field of study, since 
nowadays we are experiencing an era where the problem of antibiotic resistance becomes 
so substantial and widespread (O'Flaherty et al., 2009). P. aeruginosa is one of the 
organisms that become problematic to be successfully treated - more and more often the 
antibiotic treatments fail because an increasingly large number of strains becomes 
multiresistant towards antibiotics (Palmer et al., 2005; Sadikot et al., 2005; Sriramulu et al., 
2005). 
 
1.7. Tools to analyze the genetic diversity among P. aeruginosa strains 
The genome of the P. aeruginosa has a mosaic structure which consists of a highly 
conserved core, interrupted by variable accessory segments (Wolfgang et al., 2003). The 
core genome is represented by synteny of multiallelic conserved genes and the accessory 
genome, which include a set of genomic islets and genomic islands (Wolfgang et al., 
2003). 
Several commonly used methods of identification of the genetic diversity of bacteria, 
including P. aeruginosa, exist. Genome fingerprinting, such as Amplified Fragment Length 
Polymorphism / Restriction Fragment Length Polymorphism (AFLP/RFLP) and multiplex 
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PCR analysis (the simultaneous PCR-based generation of multiple differently sized DNA 
amplicons) often give quite big variations and, thus, are hardly comparable among 
laboratories. On another hand, MLST and MLEE methods which use nucleotide sequence 
data of, mostly, seven housekeeping genes, are rather universal, portable and definitive 
methods for bacteria characterization (Maiden et al., 1998; Maiden, 2006). However, 
MLST method provides knowledge only on the genetic diversity of the core genome, 
moreover, currently available MLST database is rather poorly annotated with the respect 
of information on type of habitat and geography of isolation of strains and, thus, is of no 
use for the study of the influence of environment on the P. aeruginosa microevolution.  
One of the latest offered methods for the genetic diversity affiliation is the method 
based on binary microarray (Wiehlmann et al., 2007), which consists of 58 targets 
representing the core and the accessory genome. The core genome is analyzed by 13 
single-nucleotide polymorphisms (SNPs) at seven conserved loci and two multiallelic loci 
(flagelin fliC and pyoverdine receptor fpvA). The accessory genome is tested with set of 
genetic markers that identify 10 genomic islets and six types of genomic islands 
(Wiehlmann et al., 2007). Moreover, current database is fairly well big and annotated: it 
contains more than 1700 isolates from 658 independent sources (both clinical and 
environmental) with the information on the origin and isolation time on majority of strains. 
Thus, the ArrayTube hybridization method (Wiehlmann et al., 2007) is at the moment 
the most promising and appropriate for the presented study. 
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2. Project rationale 
 
Despite the strong clinical focus, a result of the substantial pathogenic threat for 
humans, P. aeruginosa is widely and probably predominantly distributed as a free-living 
organism in water and soil (Gooderham & Hancock, 2009; Pirnay et al., 2009). For 
example, clone C is widespread in natural environments (Romling et al., 1994; Romling et 
al., 2005). Thus, besides nosocomial transfer, the natural environment is obviously a 
common source of infection (Curran et al., 2005; Scott & Pitt, 2004). However, only few 
studies explicitly focus on environmental strains (Khan et al., 2008; Pirnay et al., 2005), 
whereas in most population genetic studies the environmental strains are 
underrepresented (10-25%) (Pirnay et al., 2002; Pirnay et al., 2009). Nevertheless, though 
there is an obvious underrepresentation of environmental strains, most studies lean out to 
suggest clinical and environmental strains to be indistinguishable in terms of affiliation to 
(phylo-)genetic clusters or in phenotypes (Alonso et al., 1999; Kiewitz & Tummler, 2000; 
Morales et al., 2004; Ruimy et al., 2001). Also, until now, the population genetic studies 
aimed mainly at identifying or exploring the nature of the P. aeruginosa population as 
such, which resulted in the notion of P. aeruginosa to have a non-clonal epidemic structure 
(Curran et al., 2004; Pirnay et al., 2002; Pirnay et al., 2009). Yet, far less emphasis has 
been laid in further analysing the intrapopulation structure with respect to exploring the 
forces that may shape differently the observed different subgroups within P. aeruginosa 
and potentially foster their microevolutionary divergence. 
The gap in knowledge on the population structure of environmental P. aeruginosa and 
on the reciprocal interaction of P. aeruginosa with the environment can be fulfilled only by 
providing a wide spectrum study, focusing not only on the genetic traits, but also on the 
phenotypic characterization of the natural population of P. aeruginosa, which should be 
samples for by a substantially amount of isolates. Thus, this PhD thesis was designed in 
an attempt to fulfill this gap in information. 
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3. Materials and Methods 
 
3.1. Sampling places, sampling, and isolation of P. aeruginosa 
The sampling regime was designed such to sample two river systems in Northern 
Germany (Oker/Aller and Weser) over a length of each 150-200 km at approximately 
uniformly dispersed sampling sites. Among a variety of potential sampling places only 
those were utilized which were under regular monthly water quality observation by the 
Lower Saxony Ministry of the Environment (Niedersächsisches Umweltministerium,  
www.mu.niedersachsen.de). The water load concentrations for ten chemical substance 
groups (total nitrogen, ammonium, nitrate, nitrite, adsorbable organic halogen compounds, 
phosphate, sulfate, total organic carbon, total phosphate and chloride; values are available 
from the Ministry on request) are summed by the Ministry into seven classes (I, I-II, II, II-III, 
III, III-IV, and IV), ranging from I (no load) to IV (very strong load). Class II is regarded by 
the Ministry to be the target-setting for an optimal water quality. For this study, we 
averaged the water load measurements from the approximately last five years in order to 
yield via an educated guess across all ten chemical substance groups three water quality 
categories (a) low pollution (classes I, I-II, II), (b) moderate pollution (classes II-III, III,), and 
(c) strong pollution (classes III-IV, IV) for the chosen sampling places. For detailed 
information on chemical concentrations per class, see Appendix for Supplemental Table 1. 
The sampling sites were chosen such to cover approximately equal amounts of low, 
moderate, and strongly polluted sites. Altogether 13 sampling places were chosen (for 
more information on the geographical distribution of the sampling sites, see Supplemental 
Figure 10). The samplings were performed in October 2007 and July 2008. Each sampling 
was performed within two days. The samples were taken in direction of the water flow from 
the spring to the estuary. From each sampling station one liter of water was sampled in a 
sterile glass bottle and processed for strain isolation on the same day. 
For this, the water was vacuum filtered through 0.45 μm mixed cellulose ester filter (90 
mm in diameter) (Schleicher&Schuell; No. 5058945, Omnilab, Germany) (Pirnay et al., 
2005). Each liter of water was separated prior to filtration into 200 ml and 800 ml 
subsamples. After filtration, the filters were cut aseptically into three equally sized thirds, 
each of which was placed separately face up on agar plates with selective Pseudomonas 
medium (OXOID) as previously described (Pirnay et al., 2005).This procedure should 
ensure that potentially identical isolates were not a result from laboratory enrichment but 
were present as such already in the environment. The plates were incubated for 36h at 
37°C. Putative P. aeruginosa colonies, which provided a greenish-bluish color, were 
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further purified on selective Pseudomonas medium and subjected to a species-specific 
PCR targeting the oprL gene (De Vos et al., 1997). The strains were artifiacially 
concentrated and stored in 15% glycerol at -80°C. 
 
3.2. Molecular characterization of the isolates 
ArrayTube hybridizations. The P. aeruginosa isolates were genetically characterized 
using the P. aeruginosa ArrayTube system as previously described (Wiehlmann et al., 
2007). Strains for biomass production were grown for 24h at 37°C on the Pseudomonas 
agar media (Oxoid). The method is based on binary microarray (Wiehlmann et al., 2007), 
which consists of 58 targets representing the core and the accessory genome. The core 
genome is analysed by 13 single-nucleotide polymorphisms (SNPs) at seven conserved 
loci and two multiallelic loci (flagelin fliC and pyoverdine receptor fpvA). All targets are 
amplified from the P. aeruginosa colonies by the multiplex primer extension reaction with 
random labeling performed by incorporation of biotin-16-dUTP. The multiplex amplificate 
was hybridized under the high stringency with the oligonucleotide microarray of the target 
sequences that is inserted into the tip of a standard Eppendorf-like microtube. However, 
both the annealing temperature in the multiplex PCR and the hybridization incubation 
temperature were set from 60°C to 56°C in order to obtain clearer signals on the chip 
(Wiehlmann, personal communication). The hybridization signals are automatically 
converted to the multilocus genotype. The 16 binary SNP genotypes are represented by a 
four-digit hexadecimal code. The 16 SNPs are divided into four groups of four SNPs each, 
and the 16 possible combinations in each group are differentiated by 16 characters: 0–9, 
A–F (Wiehlmann et al., 2007). 
DNA extraction. Around 1.5 % percents of strains provided too mucoid biomass and 
could not be subjected directly for the ArrayTube hybridization. Thus, DNA extraction was 
performed prior hybridization. DNA was extracted by the means of the “Fast DNA SPIN for 
Soil Kit” (MP Biomedicals, LLC). DNA was extracted according to the manufacturer 
protocol. The final concentration of pure DNA in the PCR ArrayTube mix was 1.5-2 µg. 
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exoS/U multiplex PCR. In addition to the ArrayTube results the presence or absence of 
exoS and exoU genes was verified by a separate PCR as described previously (Ajayi et 
al., 2003), with two minor modifications. 
First, primers for only genes exoU and exoS were used: 
exoS (118-bp fragment) 
5’-Primer (position 686) ...........ExoS-MP5, 5’-GCGAGGTCAGCAGAGTATCG-3’ 
3’-Primer (position 804) ...........ExoS-MP3, 5’-TTCGGCGTCACTGTGGATGC-3’ 
exoU (134-bp fragment)  
5’-Primer (position 1265) .........ExoU-MP5, 5’-CCGTTGTGGTGCCGTTGAAG-3’ 
3’-Primer (position 1399) .........ExoU-MP3, 5’-CCAGATGTTCACCGACTCGC-3’ 
Second, the reaction was run in a 2.5% Agarose High Resolution (ROTH, CARL ROTH 
GMBH + CO. KG, Karlsruhe) gel with 0.5 mg of ethidium bromide/ml. 
In order to approach the whole genetic diversity of the P. aeruginosa, every each clone 
(haplotype) was subjected for the multiplex PCR; from 30% to 100% of the strains per 
clone were utilized for this analyses, depending on the size (amount of strains) and 
geographical diversity of the clone (in total a sum of 211 strains). 
Agarose gel electrophoresis. Agarose gel electrophoresis was performed according to 
Sambrook et al. (Sambrook et al., 1989). Each DNA sample was mixed with the 1/5 
volume of loading buffer and loaded on a 2.5% (w/v) gel. The TAE buffer was used as a 
running buffer. 
 
3.3. Media 
Two types of media were used: “Pseudomonas selective Agar medium”, OXOID 
(prepared according to the manufacturer protocol; Pseudomonas CN Selective 
Supplement that was used has an ordering number SR0102) and solid or liquid Luria 
Bertani Medium (LB). 
One liter of LB: 10 g of Tryptone; 5g of Yeast extract; 10 g of NaCl, and 15 g of Agar 
(only for solid media). 
 
3.4. Phenotypic characterization of the isolates 
Biofilm growth, microscopy and data analysis. In order to quantify biofilm production, 
5µl from a thawed glycerol culture were transferred into 150µl of LB within a 96-well plate. 
The pre-culture plate was covered with an air-permeable BREATHseal™ cover foil 
(Greiner Bio-One) and incubated at 37°C on a shaking unit. After 4h, 5µl of the pre-
cultures of each well/strain were transferred to 100µl LB medium within a sterile half area 
96-well µClear® microplate (Greiner Bio-One). The plates were sealed with a new air-
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permeable cover foil and placed in an incubator with a humid atmosphere for biofilm 
development. The image-based screen was carried out after 70h of incubation. The 
incubation was paused after 24h in order to stain the bacteria with the LIVE/DEAD® 
BacLight™ Bacterial Viability Kit (Molecular Probes/Invitrogen). 50µl of a diluted staining 
solution was added to each well resulting in a final concentration of 1.4µM Syto9 and 
8.3µM propidium iodide (PI). Microscopy was performed with dual-headed, confocal 
microscope (Olympus Fluoview 1000) equipped with a 20x/0.75NA air objective 
(UPLSAPO) in the middle of each well. The z-step size was 2µm. Syto9 and PI were both 
excited with a 488nm Argon-Laser and emission detected around 515nm (Syto9) and 
560nm (PI). The image-stacks obtained by fluorescence microscopy were converted to 
single bmp-images with the software Matlab® (version 7.5.0.342, The Mathworks) and 
further processed to obtain thresholded binary images using the Otsu thresholding-
algorithm. Afterwards, stacks for each position and dye were reassembled with the 
software Auto PHLIP-ML (v1.0.0) (Merod et al., 2007), now containing thresholded binary 
images instead of raw images. Analysis of the different stacks was performed with the 
Matlab implemented tool PHLIP (Mueller et al., 2006) to yield the value for “biovolume”, 
which is the descriptive parameter for the physical properties of the biofilm. 
Motility. In order to determine the swarming activity 1µl of a fresh over-night culture in 
LB broth was transferred using a custom 96-well pin device onto the surface of brain heart 
infusion agar plates containing 0.5% (wt/vol) Difco agar. Colonies were scored for 
differences in swarming motility compared to the “normal type” (the swarming size 
diameter produced by the majority of the environmental isolates) after 48h of incubation at 
room temperature. The swarming activity was semi-quantitatively classified into “minimal”, 
“normal” and “hyper” swarming strains. Similarly, for determination of swimming and 
twitching motility activity, 1µl aliquots of mid-log-phase cultures in LB broth were spotted 
onto LB agar plates with 0.3% (swimming) and 1% (twitching motility) agar (wt/vol) and 
incubated at 37°C. The diameters of the swimming zones (after 20h of incubation) and the 
twitching motility zones (after 24h and 48h) was semi-quantitatively classified into “non-
motile”, “minimal”, “normal” and “hyper” swimming and into ”minimal”, “normal” and “hyper” 
twitching activity.  
Proteolytic activity. In order to determine general proteolytic activity, 1µl of the fresh cell 
material from an LB culture was spotted onto 4% skim milk (Loewe Biochemica) agar 
plates and incubated for 24h at 37°C. Zones of clearance due to proteolytic activity were 
classified as ”no activity”, “minimal”, “normal” (the majority of strains) and “increased” 
activity. 
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Pyocyanin production. In order to determine the general level of pyocyanin production, 
5µl samples of a thawed glycerol culture were transferred into 150µl of LB within a 96-well 
plate. The pre-culture plate was covered with an air-permeable BREATHseal™ cover foil 
(Greiner Bio-One) and incubated at 37°C on a shaking unit. After 24h levels of the different 
intensities of greenish-bluish color production of the pyocyanin was classified as “normal”, 
“increased” or “strong”. 
Survival in water. LB broth was inoculated with 5µl from a thawed glycerol culture and 
incubated for 24h at 37°C. The culture was split, of which one half was washed 3x times 
with autoclaved distilled water (dH2O) and the other half with autoclaved river water (from 
the sample station ”Peine”, which is regarded as strongly polluted) The washed cells were 
resolved in autoclaved dH2O or the autoclaved river water, respectively, and adjusted to a 
cell concentration of 107 cells/ml. A volume of 1.5ml of each assay was then transferred 
into a single 4 ml flat bottom well on a 24-well culture plates (Corning Incorporated, USA) 
covered with an air-permeable BREATHseal™ cover foil (Greiner Bio-One) and incubated 
at 70 rpm at approx. 22°C (room temperature). Culturable cell counts were determined 
every 3-4 days by serial dilution plating on the Pseudomonas selective media. (OXOID). 
For a given assay, the experiment was terminated when no culturable cells were observed 
anymore in the remaining incubation fluid. In order to test for perhaps viable but not 
culturable cells remaining in the visually emptied well, the wells were further incubated with 
1 ml LB broth. In none of the subsequent LB assays cell proliferation was observed, 
suggesting indeed the death of cells during the course of experiment. Two randomly 
chosen strains from both ext_cc groups were subjected to the duplicate experiment on the 
survival in distilled water. 
Serotyping. Serotyping for O-group specific antigens was performed by using the 
“Antiserum Pseudomonas aeruginosa set” (BioRad) following the manufacturers protocol. 
First, samples were tested with the polyvalent sera: PMA, PME, PMC and PMF. 
Furthermore, monovalent sera were used - 16 monovalent sera numbered from 1 to 16. 
Polyvalent sera and monovalent sera were supplied in 3 ml dropper bottles (60 tests). 
Serotyping was performed on fresh pure cultures of P. aeruginosa grown for 24h at 37°C. 
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3.5. Phage assays 
The phages were isolated and purified from the sewage plant Steinhof in 
Braunschweig. The phages JG003, JG004 and JG005 were isolated using strain PAO1, 
the phages JG024, JG025, JG026, and JG028 were isolated using strain PA14 (Julia 
Garbe, PhD thesis 2010, TU Braunschweig, Germany; accessible at http://rzbl04.biblio.etc.tu-
bs.de:8080/docportal/servlets/MCRFileNodeServlet/DocPortal_derivate_00008650/Doktorarbeit.pdf
;jsessionid=DF821E192BF37415A09826A43ADE2AB8). To determine the phage host range, 
top-agar LB plates were prepared by adding approximately 3.5 × 10  cells of P. aeruginosa 
from an overnight LB broth to 3.5 ml of LB top agar (0.75 %). Ten µl of a phage stock 
solution (approximately 10  phage particles per ml) were spotted on the top-agar plate and 
incubated at 30°C for 24h. The lysis zone at the site where the phage suspension was 
applied was classified as “complete lysis”, “semi lysis” and “no lysis” 
8
8
(Knezevic et al., 
2009). Each phage was tested against each bacterial strain in at least duplicate in 
independent experiments. 
 
3.6. Statistical analysis. 
The non-parametric Mann-Whitney U test (MWU) was applied for comparing the 
means of two groups. For comparison of the means of three or more groups, the novel and 
robust method “multcomp” was applied (Herberich et al., 2010). All other statistical 
analyses were performed as indicated and referenced in the text. 
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4. Results 
 
4.1. The characteristics of distribution of P. aeruginosa in Northern Germany river 
systems 
P. aeruginosa was successfully isolated from all 13 sampling stations in winter and in 
12 out of 13 stations in summer (Tab. 1), with two to 56 strains per station (detailed results 
on the strains’ abundancy for every each sampling station and both seasons is available in 
the Appendix as Figure 12). A significantly larger number of isolates per sampling station 
was obtained in summer (p = 0.03; Mann-Whitney U test, MWU; column “as” in Tab. 1), 
also, the number of strains per clone is significantly higher in summer (column “s/cl”; p = 
0.011, MWU). 
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Table 1: Characteristic values for the genetic structure of P. aeruginosa in different sampling stations and seasons 
 
Station1 R2 E3 S4 Abundancies5 Haplotype configuration6 Neutrality test 
Genetic 
diversity Seasonal differences 
    as s cl s/cl  (EW/S)7 π8 (s/cl) 
Abundance9 
(as/hr) π10 (s/cl) 
Goslar O L W 4 4 1 4.0  4sol n.a. n.a. S / W n.a. 
bei Börßum O M W 8 8 5 1.6  3B  2  1 1 1 ns / ns 6.21 / 7.6 S / W S / W 
Groß 
Schwülper O M W 44 42 15 2.8 17
sol 8 4 2 (11×1) ∗ / ∗∗ 6.45 / 7.66 W / S W / W 
Peine O H W 28 18 15 1.2  8B 4  4 (12×1) ns / ∗ 6.29 / 6.86 S / S W / S 
Celle O L W 9 6 6 1.0  (6×1) n.a. 7.33 / 7.33 S / W W / W 
Han.Münden W L W 28 27 14 1.9  7S42 4 3 2 2 (9×1) ns / ns 5.33 / 6.18 W / S S / S 
Hes.Oldendorf W M W 22 22 12 1.8  5B 3 (4×2) (6×1) ns / ns 6.96 / 7.40 S / W W / W 
Ströhen W H W 15 15 11 1.4  (4×2) (7×1) ns / ns 6.65 / 7.05 0 / W W / W 
Allerbruch W H W 2 2 2 1.0  1 1 n.a. 8.00 / 8.00 n.a. n.a. 
Drakenburg W H W 9 9 7 1.3  3  (6×1) ∗∗ / ∗∗ 6.11 / 6.76 W / W W / W 
Langwedel UW L W 12 12 11 1.1  2 (10×1) n.a. 5.85 / 6.04 S / W W / S 
Brake-Weser UW H W 7 7 6 1.2  2 (5×1) n.a. 6.57 / 7.00 S / W W / S 
Brake-Sieltief UW H W 2 2 2 1.0  1 1 n.a. 5.00 / 5.00 S / W S / S 
             
Goslar O L S 11 10 2 5.0  9sol 1 ∗∗ / ∗∗ 1.00 / 5.00   
bei Börßum O M S 24 20 10 2.0  5B 4 3 2 (6×1) ns / ns 6.61 / 6.60   
Groß 
Schwülper O M S 28 20 13 1.5  4  3 2 2 (9×1) ns / ns 5.21 / 5.92   
Peine O H S 32 20 11 1.8  9B 2 (9×1) ∗∗ / ∗∗ 6.00 / 7.35   
Celle O L S 36 20 3 6.7 18F 1 1 ∗∗ / ∗∗ 0.60 / 4.00   
Han.Münden W L S 12 12 10 1.2  2 2 (8×1) ns / ns 6.20 / 6.64   
Hes.Oldendorf W M S 42 20 8 2.5 13S42 (7×1) ∗∗ / ** 5.06 / 7.32   
Ströhen W H S 15 15 3 5.0 13S42 1 1 ** / ** 1.50 / 4.67   
Allerbruch W H S 0 0 0 n.a. n.a n.a. n.a.   
Drakenburg W H S 4 4 3 1.3  2  1 1 n.a. 5.00 / 6.00   
Langwedel UW L S 18 16 8 2.0  8B 2 (6×1) ∗∗ / ∗∗ 5.46 / 7.36   
Brake-Weser UW H S 50 20 7 2.9 11B 3 2 (4×1) ns / ns 4.42 / 7.43   
Brake-Sieltief UW H S 56 20 8 2.5  6B 5 3 2 (4×1) ns / ns 6.87 / 7.50   
             
All strains   W 190 184 65 2.8 21B 17sol 14B 10sol 9 8 7 6 (3×5, 2×4, 4×3, 9×2, 39×1) ns / ∗∗ 6.93 / 6.88 S / W W / W 
   s 328 197 60 3.3 29S42 23B 18B 13B 12 11 6 (4×4, 6×3, 8×2, 35×1) ∗ / ∗∗ 6.47 / 6.72   
1 The order of the stations from top to down is in the direction of the water flow from the spring to the estuary. 
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2 R = river system, O = Oker/Aller, W = Weser, UW = Unterweser. 
3 E = ecological classification of the chemical quality (exposure) of the River System; L = low, M = moderate, H = high. For details please see the supplementary 
material 
4 designation of the sampling season; W = winter, S = summer. 
5 as = number of strains which have been isolated from 1 litre of environmental water, s = number of strains that were subjected to ArrayTube hybridization (in winter, 
most isolates per station where subjected to genetic characterization via ArrayTube hybridization, in summer, however, when more than 20 strains per station were 
isolated, a random choice of 20 strains were subjected to further genetic characterization), cl = the number of different clones among s strains, s/cl = the number of 
analysed strains (s) per clone (cl).  
6 The numbers indicate the abundancies of the observed clones in the order of their frequency. For example, in the station Groß Schwülper in winter, 15 clones were 
found. The most frequent one is represented by 17 strains, the second frequent clone by 8 strains, and 11 clones were represented by only one isolate. The affiliation 
of the most abundant clones to the exdt_cc groups is indicated by the superscript group name. In the case that the respective clone could not be affiliated to any group 
(i.e., the clone is so diverged that it has at best only triple-locus-variants in the dataset) the superscript sol (solitary) is given. 
7 EWS = Ewens-Watterson Slatkin Test for deviation from neutral expectation of the clone-frequency distribution according to the infinite allele model. EW = significant 
deviation according to the Watterson’s homozygosity test, S = significant deviation according to the Slatkin’s exact test. The significance codes are  
* 0.975 ≤ p ≤ 0.99, ** p > 0.99; two-tailed test, ns = not significant. 
8 Mean number of pairwise differences (theta π); (s/cl) = as defined above 
9 S and W indicate higher amounts of strains (as) or a higher haplotype ratio (hr) in either summer or winter, respectively. 0 = no difference between summer and 
winter, n.a. = not applicable. 
10 S and W indicate a higher theta value (theta π; the mean number of pairwise difference) among all strains subjected to ArrayTube hybridization (s) or clones (cl) in 
either summer or winter, respectively. 0 = no difference between summer and winter, n.a. = not applicable. 
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Interestingly, the increase of strains in summer does not lead to an increase in genetic 
diversity, as there is no difference between summer and winter in the genetic diversity of 
sampling stations when only clones are taken into account (p = 0.19, MWU; column π 
“(s/cl)”, Tab. 1). However, when all strains are taken into account, the genetic diversity per 
sampling station is significantly lower in summer (p = 0.012, MWU; column π “(s/cl)”, Tab. 1). 
This suggests that the entire genetic diversity is already present in winter and does not 
increase in summer. Moreover, the increase in strain numbers in summer does not occur 
uniformly for each clone. It appears as if some clones multiply far stronger than other clones. 
This is suggested by a substantially larger amount of sampling stations which diverge in 
summer from the neutral expectation according to the infinite-alleles model (Ewens-
Watterson Slatkin test, column “neutrality test”, Tab. 1). In these sampling stations, one or 
few clones are represented by significantly larger numbers of isolates than expected by a 
neutral distribution of strain numbers. It appears as if the most successful environmental 
clones belong the ecc group B (see below and see also Figure 1 and 2). 
We sought to identify by an AMOVA analysis the parameters which might influence the 
distribution of the genetic diversity of the P. aeruginosa clones, irrespective of their individual 
strain abundancies. An AMOVA analysis allows user-defined subdivisions of the dataset in 
order to determine which type of subdivision contributes measurable amounts of variation to 
the entire dataset. Neither the season (winter vs. summer) nor the geographical connection 
of the sampling stations via the same river system added any variation to the dataset (Table 
2). However, subdivision according to sampling sites of different water quality (see Appendix 
for Supplemental Table 1) added at least minor variation to the dataset. When taking into 
account only the low versus strongly polluted sampling sites, the contributed amount of 
variation (1.34%) is significant (p = 0.028) (Table 2). This suggests to some extend an 
influence of the sampling site ecology on the distribution of the genetic diversity, which will 
be analysed more deeply with Fig. 3. Interestingly, the majority of variation (> 90%) is 
contributed at the level of individual sampling stations (AMOVA, data not shown). This 
supports the observation that the genetic diversity per sampling stations, taking into account 
only one strain per clone, is in average the same as in the entire set of environmental strains 
(column “π (s/cl)”), Tab. 1). 
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Table 2. AMOVA analysis on the genetic diversity of river isolates of Pseudomonas 
aeruginosa. 
 
Source of variationa % of variation P value  
Seasonal  
(winter vs. summer) -0.06 0.51337 
Ecological  
(low vs. moderate vs. strongly polluted) 1.2 0.06752 
Ecological  
(only low vs. strongly polluted) 1.34 0.02802 
River system  
(Oker-Aller vs. Weser vs. Unterweser) 0.17 0.44485 
 
a The individual sampling places were taken as ‘populations’ (as termed in the AMOVA nomenclature) 
(Excoffier et al., 2007) and were affiliated as such into different groups as specified in the first column. 
 
4.2. The extended clonal complexes (ecc) show different population genetic 
characteristics.  
An eBURST analysis revealed the presence of six clonal complexes (cc) (Appendix 
Figure 11). A cc is defined by a founder clone and all further clones that are related to the 
founder clone by a series of single locus variants (SLV) (shaded in grey, Fig. 1a). SLVs differ 
in one out of 17 core genomic markers. 
 
 
 
Figure 1. The structure of the genetic relationships among the P. aeruginosa host strains 
as based on eBURST analysis of the core genome SNP pattern. Pink clones are represented by 
both clinical and environmental strains. Uniquely clinical or environmental clones are coloured in green or in 
black, respectively. The founder strain of the clonal complexes is coloured in blue. The clones listed in the 
rectangular grey shaded box left-sided in Fig. A), B) and C) do not have any SLV or DLV within the entire 
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dataset. (A) The clonal complexes and all their within SLV variants are shaded in grey. The clonal complexes 
are named according to the clone designation of their founder strains. (B) The SLV and DLV of all founder 
strains are shaded in grey. Dark grey lines indicate DLV of the founder strains, even if they may belong to other 
clonal complexes. (C) The clonal complexes and all strains affiliated via a series of DLV with the respective 
clonal complexes are shaded in grey. All DLV connections present in the dataset are shown by blue lines (both, 
DLV within an extended clonal complex and DLV across extended clonal complexes). D+E) UPGMA 
cladograms as deduced from Fst values from the groups as defined in Fig. 2B and 2C, respectively. 
 
A founder is defined to be that clone which has the maximum number of different SLV 
clones. However, a cc is a biased way to classify clones into genetic groups, as, eg., five 
locus variants (which differ at five positions from the founder) may be included into a cc as 
long there is a linking series of SLV clones to the founder (see cc S19, Fig. 1a), whereas 
double locus variants (DLV) might be excluded if there is no connecting SLV clone in the 
database (see cc Y, Fig. 1a and b). We therefore sought to classify the clones related to a 
founder strain in a more unbiased way and at two levels of resolution. The first level 
encompasses all the SLV and DLV from a given founder, even if a DLV from one founder 
strain might be member of the cc from another founder strain (Fig. 1b). The second level of 
resolution encompasses the original cc (Fig. 1a) and all those clones which can be affiliated 
by DLV connections to one of the clones within a cc.  We term this group extended clonal 
complex (ecc) (Fig. 1c). We realized that such a way of clustering is more reliable than by a 
phylogenetic tree based on neighbour joining or maximum parsimony methods (data not 
shown). For the so defined groups at both levels of resolution (Fig. 1b and c) we determined 
from the clone information (i.e., one strain per clone) the FST values, a measure for the short 
term genetic distances between populations (Reynolds et al. 1983; Slatkin, 1995), as input 
for an UPGMA analysis of genetic similarity of the ecc to each other (Fig. 1d and e), 
respectively. Both levels of resolution indicate F and S19 as well as Y and S42 to be closely 
related groups of clones (Fig. 1d and e). At the first level of resolution (Fig. 1b) it appears as 
if group B is somewhat quite distantly related to all other groups (Fig. 1d). This strong 
genetic distance is attenuated when also those strains are taken into account, which are 
more distantly related to the founder strains (Fig. 1c and e). 
Group B is obviously the most dominant group, followed by S19, F, and S42 (Table 3). 
The number of strains per clone, however, deviates substantially among the ecc groups 
(Table 3). 
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Table 3: Genetic characteristics of the ecc groups 
 
Statistics B E71 Y S42 F S19 ALL 
Diversity:  
Number of strains (% of all 
[309]) 127 (41.1) 15 (4.9) 15 (4.9) 
47 
(15.2) 49 (15.9) 56 (18.1) 309 (100) 
Number of different strains 
(% of all haplotypes [88]) 17 (19.3) 15 (17.0) 9 (10.2) 
12 
(13.6) 12 (13.6) 23 (26.1) 88 (100) 
Mean number of strains per 
haplotype 7.47 1 1.66 3.91 4.08 2.43 3.51 
Mean number of pairwise 
differences (all strains) 4.26 3.18 2.06 2.17 2.09 3.92 6.61 
Mean number of pairwise 
differences (only 
haplotypes) 4.88 3.18 2.44 5.03 2.88 3.91 6.55 
Ewens-Watterson 
neutrality test:  
haplotype configuration 44 19 16 15 
7 (3×3) (3×2) 
(5×1) 
15×1 (3×3) (6×1) 33 3 2 
(9×1) 
18 12 6 3 2 2 (6×1) 7 6 5 (2×4) (3×3) 
(3×2) (11×1) 
44 33 19 18 16 15 12 
(2×7) (3×x6) 5 (3×4) 
(10×3) (9×2) (52×1) 
Observed F value 0.18023 N.A. 0.14667 0.50294 0.21949 0.06633 0.05028 
Expected F value 0.16204 N.A. 0.15336 0.17726 0.18016 0.08033 0.02682 
Watterson F p-value 0.726 N.A. 0.569 1 0.824 0.16 0.99 
Slatkin's exact p-value 0.712 N.A. 0.569 1 0.887 0.258 1 
linkage disequilibrium:  
IAS 0.0566 -0.0082 -0.0184 0.0667 -0.0004 -0.0077 0.0485 
P (H0: VD = Ve) < 0.0001 0.79 0.89 0.0014 0.44 0.85 < 0.0001 
Mean genetic diversity 0.2872 0.1871 0.1438 0.2959 0.1693 0.2297 0.3856 
genetic structure “clonal” “recombinogenic“ “recombinogenic“ clonal “recombinogenic“ “recombinogenic“ clonal 
 
The values for diversity and Ewens-Watterson neutrality test were calculated using Arlequin 3.5 (Excoffier et al., 2007). 
The null hypothesis for linkage equilibrium for multilocus data was tested using LIAN3.5 (Haubold & Hudson, 2000).  
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Although the haplotype configuration of all strains affiliated to any of the ecc groups 
deviates from neutrality according to the EWS test (Table 3), most individual ecc, 
excluding S42, do not deviate from neutrality. With respect to recombination of genes as a 
result of potential horizontal gene transfer, the structure of all clones affiliated to the ecc 
groups is rather clonal, as the standardized Index of Association IAS deviates significantly 
from zero (Table 3, column “all”). However, at the level of individual ecc, the groups E71, 
Y, F, and S19 appear to be recombinogenic, whereas groups B and and S42 are rather 
clonal (Table 3). 
 
4.3. The heterogeneous distribution of the ecc groups in sampling stations of 
different water quality. 
We sought to explore whether the six ecc groups (Fig. 2) are uniformly distributed in 
the environment or whether they differ in abundance or in distribution across sampling 
places of different water quality (low, moderate, and strongly polluted water). 
 
 
 
Figure 2. Distribution of P. aeruginosa ecc groups in Northern Germany rivers with 
respect to (a) ecological preferences and (b) sampling frequency. For both (a) ecological 
preferences and (b) sampling abundancies, the characteristics of the entire dataset is assumed to be the 
expected distribution under the hypothesis of a uniform distribution of P. aeruginosa and is compared to the 
distributional characteristics of subsets (observed distribution). The observed distributions are shown as 
white (low), grey (moderate) and black (strong pollution) columns in the foreground, whereas the expected 
distribution is shown as zigzag shaded column in the background, respectively. The degree of deviation 
between expected and observed distribution is assessed using the chi-square test. The significance codes 
for the p-values are 0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05. For both approaches (a) and (b), two measurement criteria 
are applied, (i) the total amount of isolates, and (ii) the number of successful sampling occasions.  
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However, with respect to measure (i), the isolation of a large number of strains from, e.g., only a single 
haplotype of a given ecc group from only a single sampling site per given water quality group (low, moderate 
or strongly polluted) might erroneously be interpreted as a substantially large environmental distribution and 
relevance of a given ecc group in a given habitat, though it might just be the result from a very local outburst. 
This may lead to a bias in data analysis from measure (i). In order to accommodate for such a potential bias, 
we introduced a second abundance measure (ii), which records only the number of independent successful 
sampling occasions in which any haplotype of a given ecc group has been isolated from any individual 
sampling place per given water quality group, irrespective of the number of strains. 
 
For this, we analysed the same dataset following two approaches. First, we focus on 
the individual ecc group and its distribution across sampling places of different water 
quality (Fig. 2a). Under the null hypothesis of a uniform distribution we expected a 
distribution according to the relative proportion of low (32%), moderate (24%), and strongly 
polluted water (44%) sampling places among all positive sampling places (N=25, see also 
Tab. 1). Second, we focus on the three different habitat types (low, moderate, and strongly 
polluted water) and study the relative proportions of the six ecc groups within these 
habitats. Here, the expected relative proportion is based on the ecc group size, which is 
the relative proportion of the number of clones per individual ecc group (see also line 2 of 
Table 3) among all clones encompassed in the six ecc groups (N=88, Table 3) (Fig. 2b).  
According to the first approach, group Y is uniformly distributed in the three habitat 
types (Fig. 3a). In principle, this holds also for groups B and E71, though different types of 
sampling success measures show slight deviation from a uniform distribution (Fig. 2a). 
The groups S42, F, and S19, however, differ substantially from the expected distribution, 
as supported from both measures (i) and (ii) (Fig. 2a). Moreover, these groups differ in the 
mode of divergence from a uniform distribution. Group S42 is underrepresented in clean 
water, but rather overrepresented in moderate water. Group F shows a strong 
overrepresentation in clean water but an underrepresentation in strongly polluted water. 
Finally, group S19 is underrepresented in clean and strongly polluted, but overrepresented 
in moderately polluted water.  
The second approach (Fig. 2b) focuses on sampling abundancies of the six genetic 
grouped with respect to the three different habitat types. Interestingly, in all habitat types 
the actual sampling abundancies differ from the expected sampling abundancies 
according to the clone sizes of the groups. To a very large extend this is due to the 
overrepresentation of group B strains in all three habitat types. In contrast, groups E71 and 
Y appear to be underrepresented in all three habitat types (Fig. 2b). In support of Fig. 2a, 
also the sampling abundancies depict the underrepresentation of S42 in low polluted 
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water, the preference of group F for low polluted water, and the underrepresentation of 
group S19 for both low and strongly polluted water (Fig. 2b).  
 
4.4. Different laboratory survival rates of P. aeruginosa in water of different quality. 
The results from Fig. 3 suggest that individual ecc groups may show a tendency to 
prefer or to avoid specific levels of water quality or to show a general overrepresentation 
irrespective of the water quality. For example, group S42 is hypothesized to avoid clean 
water (Fig. 3 A and B). In order to test this hypothesis we chose a random subset of clones 
from S42 and B (five and seven clones, respectively, with one strain per clone) in order to 
monitor their cell survival in water. In autoclaved distilled water, viable cells of all strains 
are measurable until day 7. On day 11, however, only one out of five strains (20%) from 
group S42 still shows viable cells, whereas on day 14 no viable cells from any of the S42 
strains were detectable anymore. In contrast, all seven strains (100%) from group B show 
viable cells until day 25 (Fig. 3 A1). Although, on a qualitative level, all strains from groups 
S42 and B showed viable cells until day 7, we observed on a quantitative level of the 
number of viable cells already a substantial decline of S42 in comparison to B. On both 
day 4 and 7, the strains of group S42 show a lower amount of living cells than the strains 
from group B (Fig. 3 A2). In sum, these survival experiments on the artificial laboratory 
environment support the hypothesis from the abundance distribution in the natural 
environment (Fig. 3). 
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Figure 3. Culturability of strains from the groups B and S42 in distilled water (A) and 
strongly polluted autoclaved river water (B). Black and grey fills denote group B (seven clones) and 
group S42 (five clones), respectively. Each clone is represented by a single strain. The y-axis denotes on a 
logarithmic scale the amount of cells (%). Fig. (A) indicates the amount of culturable cells in comparison to 
the inoculated number of cells (107 cells, 100%). Fig (A1) shows the proportion of strains which were still 
detectable by culturable cells after the days indicated. The viable cell count data seven group B and five 
group S42 strains are summarized as box-plots (median, 25%-75% quartiles and the minimum and 
maximum values) – Fig. (A2).  
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4.5. Environmental ecc groups differ from clinical ecc groups in motility and 
virulence phenotypes.  
In the environmental strains, for all addressed phenotypes the dominant phenotype is 
“normal”, with in general more than 60%-80% of all clones per ecc (Fig. 4). Other 
phenotype variants such as “none”, “minimal”, and “hyper” are usually at a level of 10-
20%. In clinical strains, the proportions differ. For example, in swarming and twitching 
motility, the variants “normal” and “minimal” are approximately equally distributed at 40%-
50%. In the phenotype swimming there is a partial reduction in the “normal” variant in ecc 
groups Y and F, leading respectively to an increase in the variant “minial”. In the 
phenotype of proteolytic acitivity the difference is even more obvious, as as the variants of 
“minimal” and “none” often exceed the variant “normal”. In sum, the differences between 
environmental and clinical ecc groups are significant at “normal” for proteolytic activity, 
swimming, swarming, and twitching motility (p = 0.006 to 0.024, MWU) and at “minimal” for 
proteolytic activity and swimming (p = 0.037 and 0.006, respectively; MWU). 
Environmental and clinical strains do not differ in their pyocyanin production. The 
difference between ecc from either environmental or clinical origin is far less pronounced 
than between environmental or clinical habitats. Only occasionally some substantial 
differences are observed. For example, the environmental ecc group B has a rather low 
proteolytic activity, whereas the clinical ecc group B is characterized by a rather large 
twitiching motility potential (Fig. 4).  
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Figure 4. Quantitative determination of virulence and motility phenotypes among the ecc 
groups from clinical and environmental origin. The semi quantitative category “normal” always 
indicates the phenotype expressed by the majority of environmental strains. “Total” inidicates all clones that 
could be affiliated to any of the ecc groups. *p-value below 0.05, **p-value below 0.01 (Chi2 test). 
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4.6. Biofilm forming capabilities differ between clinical and environmental strains, 
but not among the ecc groups. 
Within each ecc group, there is no significant difference between environmental and 
clinical strains when comparing the mean values of the total biovolume (Fig. 5, MWU). 
Also, across either environmental or clinical origin, there is no significant difference among 
the ecc groups in their mean values [R package multcomp, (Herberich et al., 2010)]. 
Nevertheless, the clinical strains obviously show larger extreme values with respect to 
higher biovolume, which suggests a non-normal distribution and skewness of the clinical 
data. This is indeed the case, as none of the environmental (excluding B, p = 0.03, 
Shapiro-Wilk test) but all of the clinical ecc groups (except Y) show significant deviation 
from normality (p = 0.00001 to 0.0034; Shapiro-Wilk test). Moreover, the clinical ecc 
groups appear to have also the smaller extreme values than their environmental 
counterparts, which suggest the clinical groups to have a larger variance. This is the case, 
as the variance values from the six environmental ecc groups are significantly larger than 
from the six clinical groups (p = 0.016, MWU). Thus, environmental and clinical strains do 
not differ in biofilm formation in their mean values, but in a larger spread (variance) around 
the mean value, with a tendency for few strains per each ecc clinical group to show a 
substantially increased biofilm formation. 
 
Figure 5. Ability to form biofilm. The box-plots show median, 25-75% quartiles and the minimum 
and maximum values. 
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4.7. The phenotypic characterization of seven environmental phages based on their 
lysis behaviour on 99 environmental clones of P. aeruginosa. 
Amongst a set of 30 phages isolated from a waste water plant near Braunschweig, 
Germany (Julia Garbe, PhD thesis, TU Braunschweig; accessible at http://rzbl04.biblio.etc.tu-
bs.de:8080/docportal/servlets/MCRFileNodeServlet/DocPortal_derivate_00008650/Doktorarbeit.pdf
;jsessionid=DF821E192BF37415A09826A43ADE2AB8), we first explored in detail the lytic 
behaviour of the most successful seven phages on the set of 99 environmental P. 
aeruginosa clones (one strain per clone).  
The proportion of lysed strains (either clear lysis or semi lysis) ranges from approx. 70% 
(JG005) down to 35% (JG026) (Tab. 4). The relative proportion of clear lysis phenotype among all 
lysed strains varies considerably from 88% (JG004) down to 12% (JG028) (Tab. 4). 
 
Table 4. The distribution of lysis phenotypes of seven phages across 99 environmental 
Northern Germany river clones of P. aeruginosa 
 
Lysis phenotype Number of lysed strains by phage 
 JG004 JG005 JG003 JG024 JG025 JG028 JG026 
Clear lysisa 43 (88) 49 (70) 35 (57) 22 (45) 9 (19) 6 (12) 8 (23) 
Semi lysisa 6  (12) 21 (30) 26 (43) 27 (55) 39 (81) 46 (88) 27 (77) 
No lysis 50 29 38 50 51 47 64 
 
a percentage of lysis when the sum of clear lysis and semi lysis is taken as 100% 
 
We sought to determine the phenotypic lysis similarity relationships between the 
phages. For this we determined for all 21 pairwise combinations of phages the proportion 
of host strains which are lysed by both phages in the respective combination. For example, 
from all strains which are lysed by either phage JG025 or JG028, 81% are lysed by both 
phages, which indicate a high phenotypic similarity between JG025 and JG028 (Appendix 
Fig. 6a). In contrast, for phages JG004 and JG026, only 27% of strains are lysed by both 
phages, which indicate a rather low phenotypic similarity. These results suggest two 
phenotypically distinct groups of phages which we term group phA (phages JG025, 
JG028, and JG026) and group phB (phages JG004, JG005, and JG003) (Fig. 6). Phage 
JG024 appears to be phenotypically distinct from both phA and phB (Fig. 6). Group phA 
appears to be substantially more effective against the hosts strains, as both the ratio of 
lysis versus non lysis and the ratio of clear lysis versus semi lysis is higher in comparison 
to group phB (Tab. 4). 
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Figure 6. Phenotypic lyses similarity (UPGMA) among seven environmental phages. 
 
4.8. Divergent susceptibility to lytic phage attack among both different ecc groups 
and among strains from clinical versus environmental origin.  
We observed several differences between the six ecc groups in their lysis susceptibility 
towards both all phages and the individual phage groups phA and phB. Compared across 
all seven phages, only the clinical exx groups Y and 42 differed signficantly from each 
other (Fig. 7, Table 5). In the phenotype “no lysis”, the groups B and S42 showed in 
several instances significantly higher resistance compared to Y and S19 (Fig. 7, Table 5). 
4. Results 
Table 5: Significant differences in lysis susceptibility between ecc groups (Fig. 7) 
 
 All seven phages Phage group phA 
(JG003, JG004, JG005) 
Phage group phB 
(JG025, JG026, JG028) 
 Complete 
lysis 
Semi lysis  No lysis Complete 
lysis 
Semi lysis  No lysis Complete 
lysis 
Semi lysis  No lysis 
Environmental 
strains 
n.s. n.s. 
S19 – B ** 
Y – B ** 
Y – S42 ** 
S19 – S42 
** 
B – S19 *** 
B – S42 ** 
B – Y  ** n.s. n.s. 
S42 – E71* 
 
n.s. 
Y – S42 * 
Y – B * 
Clinical 
strains 
Y – S42 * 
n.s. 
Y – S42 * B – E71 * 
B – F * n.s. 
S42 – S19 * Y – F * 
Y – S19 * 
Y – S42 * 
Y – E71 ** 
Y – S42 * 
Y – S42 * 
Environmental 
and clinical 
strains n.s. n.s. 
Y – B * 
Y – S42 *  
S19 – S42 * 
B – S19 * 
n.s. n.s. 
Y – E71 * 
Y – S19 *** 
Y – S42 * 
Y – F * 
n.s. 
Y – S42 * 
 
All comparisons were performed using the multcomp package in the open-source software R (http://www.r-project.org/) (Herberich et al., 2010). Only significantly 
different pairwise combinations are listed. Ecc groups listed in bold and underscore have the larger percentage values as shown in Figure 7. The significance codes 
are 0 '***' 0.001 '**' 0.01 '*' 0.05 '. n.s. = there is no significant difference among any of the groups. 
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Figure 7. Phage lysis phenotype versus genetic diversity of host strains. The 
proportions (%) of complete lysis (black bars), semi lysis (shaded bars) and no lysis (white bars) of the 
individual phages and the average across all phages are plotted against the different genetic groups 
within the hosts’ strains. The column “all ecc” encompasses all strains which could be grouped to any 
ecc group (see also Fig. 2c). The column “all” encompasses also those strains which do not have any 
double-locus variant (DLV) within the dataset. Each of the eight subcolumns are headed by a series of 
three numbers, indicating the amounts of environmental strains (normal underscore), clinical strains 
(italic) and the sum of both (bold faced). Within each lysis phenotype, the first bar indicates 
environmental strains, the second bar indicates clinical strains, and the third bar indicates the sum of 
both (see the numbering on the x-axis). 
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At the level of the individual phage groups phA and phB, these differ obviously in 
their lytic potential towards individual ecc groups. Group B is significantly more 
resistant to complete lysis by phages from phA than several of the other ecc groups 
(Fig. 7, Table 5). However, ecc group B does not differ from the other groups with 
respect to phage group phB. Here, group Y is significantly more sensitive to phB 
attack (complete lysis) than the other ecc groups. Interestingly, Y differs also in semi-
lysis and no lysis by phB from its closely related sister group S42 (Fig. 7, Table 5).  
We further observed clinical strains to be apparently more sensitive to phage 
attack than environmental strains. First, when measured across all seven phages, 
the ecc groups B and Y showed significantly higher complete lysis rates among the 
clinical versus environmental strains (p = 0.045 and  p = 0.024, respectively; MWU; 
Fig. 7). Second, when measured across phages JG025 and JG028 only, the clinical 
strains showed a higher complete lysis ratio among all 6 ecc groups (p = 0.0064 and 
p = 0.0050, respectively; MWU; Fig. 7). As these two snapshots could suggest a 
general trend of a larger phage sensitivity of clinical strains, we sought to verify this 
pattern accross all 42 combinations of phage versus ecc group (7 phages x 6 ecc 
groups = 42). Interestingly, a significantly larger number of combinations showed a 
higher proportion of complete lysis phenotype within the clinical strains (30 out of 39, 
3 combinations were equal; p = 0.0011, sign-test). Also, in a significantly larger 
number of combinations the environmental strains showed a higher proportion of 
the“no lysis” phenotype (27 out of 37, 5 combinations were equal; p = 0.0076, sign-
test). This suggests a strong and significant tendency of clinical strains to become 
more phage sensitive, irrespective of the type of phage and the ecc group affiliation 
of the host strains. 
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4.9. The ecc groups differ in their serotype composition. 
The most frequent serotypes are 6 and 1, followed by serotypes 3 and 4 (Fig. 8c). 
In general, this distribution is true for both environmental and clinical strains (Fig. 8a 
and b).  
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Figure 8. Distribution of the serotypes among the ecc groups. The stacked bars 
indicate the relative proportions [%] of the serotypes among the six ecc groups from environmental (a) 
or clinical (b) origin or within the pooled environmental and clinical data (c). The stacked bar 
designated “all“ encompasses all strains which could be grouped to any ecc group (see also Fig. 1c). 
The numbers within the bars indicate the serotypes. The designation “7,8“ indicates all serotypes that 
are either 7 or 8, as these serotypes are often indistinguishable. Stacks without a label indicate 
serotypes with 3% or less frequency in the respective dataset. The relevant serotypes are coloured in 
light grey, dark grey, or black. Striped stacks from lower-left to upper-right indicate not typable 
serogroups; striped bars from upper-left to lower-right indicate polyvalent serotypes. The numbers on 
top of the bars indicate the absolute numbers of strains per bar. 
 
The major difference between environmental and clinical strains lies in the large 
proportion of polyvalent serotypes in the clinical strains (Fig. 8b). Interestingly, the 
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serotypes are far from being uniformly distributed among the ecc groups. E71 is 
dominated by serotypes 6 (>50%) and 1 (>10%) in both environmental and clinical 
strains. In contrast, in group B serotype 6 is present only in a small amount (5%) 
among the clinical strains and not at all in the environmental strains. Instead, group B 
appears to be dominated by serotypes 10, 11, and 1. The closely related groups Y 
and S42 (see also Fig. 1d and e) are characterized by a rather uniform distribution of 
a large number of serotypes, with some small preference for serotypes 1, 3, and 4, 
but less for serotype 6. In contrast, the closely related groups F and S19 (Fig. 1d and 
e) show both again a rather large abundance of serotype 6 and 1, and also of 
serotypes 4 and 9 in the groups F and S19, respectively. In sum, we observe a 
substantial diversity of serotype distribution among the different ecc groups.  
 
The full table of the phenotypic characteristics and test results is available in 
Appendix as Supplemental Table 3. 
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5. Discussion 
 
P. aeruginosa has gained scientific importance because of several reasons. First, 
it is an opportunistic pathogen causing severe diseases in humans. Second, the 
genome of P. aeruginosa is well equipped with a large number of genes involved in 
transport and efflux of organic compounds, in intrinsic drug resistance and also in 
biofilm formation and quorum sensing (Govan & Deretic, 1996; O'Toole & Kolter, 
1998a; Poole, 2001; Schuster et al., 2003; Stover et al., 2000b). These features 
enable P. aeruginosa to thrive in a large number of substantially different and also 
extreme environments. Besides rather common habitats such as soil, water, plants, 
and different animal and human body compartments, P. aeruginosa replicates also in 
sodium dodecyl sulfate (Hagelueken et al., 2006) and contrast media (Tress et al., 
1994). This impressive versatility, together with its ubiquitous distribution, has lead to 
the notion that P. aeruginosa strains thrive equally well in different habitats. As such, 
it has been frequently stated that there is no difference between P. aeruginosa 
strains from different environmental or clinical habitats (Alonso et al., 1999; Foght et 
al., 1996; Kiewitz & Tummler, 2000; Morales et al., 2004; Ruimy et al., 2001).  
A consistent interpretation of this notion would imply that P. aeruginosa is hardly 
affected by selective pressures, as its genetic versatility may readily repel any biotic 
or abiotic threats. If this were true, in consequence, natural genetic drift would be 
responsible as major factor of any observable population structure in P. aeruginosa. 
Although natural genetic drift is unquestionably an important evolutionary force (Hartl 
& and Clark, 2007; Lynch & Conery, 2003; Lynch, 2006), drift has been found to be 
rather dominant in bacteria with a very narrow ecological niche such as obligate 
endosymbionts (Herbeck et al., 2003; Kuo et al., 2009), whereas P. aeruginosa is 
ecologically ubiquitously distributed. Indeed, numerous studies show the 
susceptibility of P. aeruginosa to selective pressures while microevolutionary 
adapting to the human habitat (Ciofu et al., 2010; Hogardt et al., 2007; Smith et al., 
2006a; Sriramulu et al., 2005). Therefore, in contrast to indirect implications (Alonso 
et al., 1999; Foght et al., 1996; Kiewitz & Tummler, 2000; Morales et al., 2004; Ruimy 
et al., 2001), it is reasonable to expect that selective pressure exerted by different 
types of natural environments may also affect P. aeruginosa in the natural 
environment. 
The contemporary consensus is that P. aeruginosa is characterized by a non-
clonal epidemic population structure. “Epidemic” is defined by the world health 
organisation as “the occurrence in a community or region of cases of an illness, 
specific health-related behaviour, or other health-related events clearly in excess of 
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normal expectancy” (http://www.who.int/hac/about/definitions/en/index.html status 22 
June 2010). Adopted to P. aeruginosa, “epidemic” apparently refers to certain 
frequently sampled clones, e.g., the famous clone C (Romling et al., 1994; Romling 
et al., 1995) or the entirely clinical MDR serotype O:12 group (Giammanco et al., 
1985; Pirnay et al., 2009; Watine, 1999). On a geological scale, epidemic clones may 
be the result of sudden outbursts and may therefore disappear also similarly sudden, 
once the acute selective advantage diminishes. However, also the remainder and 
mostly majority of the genetic diversity of a species exhibit usually a characteristic 
genetic structure, which may be far from a uniform mix. Often, the genetic diversity of 
a species assembles into more or less distinct genetic groups or lineages, each of 
which may consist of numerous different clones. In contrast to epidemic clones, 
which may appear and vanish again (Achtman, 1997), these lineages are rather 
robust on a geological scale. Numerous studies have shown such lineages also to 
exist in P. aeruginosa, though they have until now received only few attention. In our 
study, we term these lineages extended clonal complexes (ecc). Here, we study the 
characteristics of these ecc with respect to environmental and clinical habitats. We 
will discuss selective forces which appear to be cohesive for the ecc and which 
thereby may drive the further diversification (cladogenesis) of these lineages, 
irrespective of occasionally emerging epidemic clones. Unless going extinct, it is 
reasonable to expect that they will ultimately lead to the emergence of novel species 
from the current P. aeruginosa pool. 
 
5.1. Nonrandom distribution of extended clonal complexes in German river: 
eccB emerges as a dominant aquatic ecotype 
The AMOVA study indicated that neither the season of isolation (winter versus 
summer) nor the geographical distribution of isolates (river Weser versus river 
Oker/Aller) appeared to contribute any influence on the genetic diversity of isolates 
(Table 2). We do, however, observe a larger amount of isolates in summer than in 
winter, probably as a result of the higher temperature which may enable better 
growth (Table 1) (Pirnay et al., 2005). Yet, neutrality tests on the haplotype 
configuration indicate that not all clones appear to benefit equally well from the 
temperature shift. In contrast, it appears as if only few clones benefit and increase 
disproportionally high (Table 1), which may suggest that some clones may respond 
differently to environmental challenges. In accord with this observation, the AMOVA 
study suggested some influence of the water quality of sampling stations (as defined 
by the chemical load determined by the Lower Saxony Ministry of the Environment) 
on the genetic diversity of the strains (Table 2). This is in so far interesting as, 
compared to the tremendous differences in the habitats in which P. aeruginosa may 
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reside globally, the differences in water quality appear to be marginal. Motivated from 
these insights, we sought to explore if potential differences in response to 
environmental challenges relate to the genetic lineages (extended clonal complexes, 
Fig. 1) we identified. Indeed, some ecc apparently prefer rather clean water 
compared to strongly polluted water (eccF), others thrive rather in strongly polluted 
water and appear to avoid clean water (eccS42), whereas others again are equally 
abundant in all three levels of water quality (eccB, E71) (Fig. 2). Survival experiments 
in laboratory assays (Fig. 3) supported this observation and suggested rather direct 
and immediate effects on the viability/culturability of the cells. 
Another interesting feature is the dominance of eccB in our samples, irrespective 
of the water quality (Fig. 2). Specifically in summer, the eccB group is often the most 
sampled group per sampling station. From a genetic perspective, eccB is quite 
distinct from the other ecc, especially when taking only the founders and its closest 
relatives into account. These findings suggest eccB to be better adapted to 
environmental water than the remainder of P. aeruginosa, i.e., to constitute a 
potential water ecotype. We do note that we base our assumptions only on cultivation 
data, whereas molecular methods might show alternative results. Even if this were 
the case, the readily culturability of eccB may also suggest a better physiological 
adaptation to environmental water. For a global comparison, we have kindly been 
supplied from different authors with representative strains from previous studies (see 
Appendix for Supplemental Table 2). Interestingly, our findings of eccB to be a 
perhaps specific water ecotype gains support from a recent study on water isolates in 
Japan. Khan et al identified eccB to be distinct open ocean isolates which were 
rather absent from fresh water river or bay water (Khan et al., 2007). The authors 
supported their hypothesis of a better adaptation of the open ocean isolates to higher 
salinity by laboratory microcosm survival experiments, in which the marine strain 
performed at 7% NaCl indeed better than the freshwater or clinical isolate (Khan et 
al., 2007). Thus, the study by Khan et al supports the hypothesis of eccB being a 
probably characteristic environmental water ecotype within P. aeruginosa. Also, 
among 30 isolates from Japanese rivers isolated more than 35 years ago (Mutharia 
et al., 1982), eccB was the dominant group (together with eccF, each 8 isolates). 
Another, indirect, evidence comes from a recent very comprehensive study of 328 
globally spread isolates, amongst them 55 environmental water isolates (Pirnay et 
al., 2009). In this study, eccB is equivalent to the MST groups F and G (Pirnay et al., 
2009). Comparable to our results and to the japanese water isolates (Khan et al., 
2007; Khan et al., 2008), the MST groups F and G are obviously genetically and 
phenotypically distinct from the rest of P. aeruginsa (Pirnay et al., 2009). In the eccB 
group of that study (Pirnay et al., 2009), the environmental water clones are 
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significantly overrepresented in comparison to the other groups. In sum, our data and 
those from several other studies support the notion of eccB to be an evolutionary 
lineage being better adapted to environmental water than other lineages of P. 
aeruginosa. However, whereas a study on the P. aeruginosa diversity of the Belgian 
river Woluwe also identifies the eccB group to be genetically and phenotypically 
different from the other P. aeruginosa groups, eccB was not abundantly sampled in 
this study (Pirnay et al., 2005). Thus, in terms of sampling abundancy of eccB, the 
river Woluwe in Belgium obviously differs from the German river systems of 
Oker/Aller and Weser. 
Besides its genetic distance from other ecc and apparently superior 
environmental adaptation, eccB differs from other P. aeruginosa lineages by its 
exoS/exoU characteristics. ExoS and ExoU are virulence effector molecules. These 
are injected into the host cell by the type III secretion system. It has been reported 
that ExoS is an important toxin required for colonization and dissemination during 
infection, whereas ExoU is mainly associated with increased virulence (Lin et al., 
2006; Schulert et al., 2003; Shaver & Hauser, 2004). In the overwhelming majority of 
cases (>98%), a strain has either the exoS or exoU gene, whereas having both or 
neither genes is extremely seldom. The most common combination of these virulence 
factors is the combination exoS+/exoU-, which is found in the literature at a frequency 
of approximately 70% of all yet studied strains, followed by the second frequent 
combination of exoS-/exoU+ (Feltman et al., 2001; Pirnay et al., 2009). In accordance 
with the previously published results, the combination exoS+/exoU- is the most 
abundant (around 73%) in the here studied population, also, if to consider the 
population as whole, around 27% of it, has the combination of exoS-/exoU+, present 
in all ecc, irrespective of environmental or clinical origin. However, this combination of 
exoS-/exoU+, we find in our environmental strains only in eccB (in both environmental 
and clinical strains at approximately 60%), and to a very low frequency (7%) in the 
clinical eccS42 strains. The very seldom combination of exoS-/exoU- is also present 
only in group eccB, in the most abundant haplotype B30 (see Figure 12 in the 
Appendix section). It is currently unclear if this apparent linkage of adaptation to 
environmental water bodies and the presence of the exoU gene are of any biological 
relevance or if this is just a result of a random evolutionary chance. 
In sum, our findings show that the dispersal of P. aeruginosa clones in different 
environmental water bodies is by far not random or uniform. This indicates that the 
microevolutionary dynamics of P. aeruginosa is substantially affected by the natural 
environment (Khan et al., 2007). 
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5.2. Phages as driver of cladogenesis in P. aeruginosa 
It is well accepted that viral numbers exceed those of bacteria, and that lytic 
phages as predators are a major source of mortality of bacteria in aquatic habitats 
(Suttle, 2007; Weinbauer, 2004). This leads to dynamic phage-host relationships, 
which indicates the huge impact phages may have on the evolution of their hosts 
(Forterre, 2006).The mortality pressure of phages resulted in the increasing interest 
of phages as therapeutical agents for microbial infection diseases (Debarbieux et al., 
2010; McVay et al., 2007; Merabishvili et al., 2009; Thiel, 2004; Watanabe et al., 
2007). Also P. aeruginosa is under a strong worldwide selective pressure by phages 
(Ceyssens et al., 2009). Though phages show frequently a quite narrow host 
spectrum, limited to one or few species, phages usually do not lyse all strains of a 
single species (Weinbauer, 2004). Recent rather extensive studies on the phage-host 
relationships in P. aeruginosa documented that even the most effective phages do 
form plaques on only approximately 55% of the tested host strains (Ceyssens et al., 
2009; Knezevic et al., 2009). Interestingly, it has until now not been explored if the 
phenotype of resistance or susceptibility to phages is rather uniformly distributed 
across the hosts diversity or not. Such insight, however, would allow addressing the 
impact of phages on the emergence, cohesion and further divergence of the deeper 
phylogenetic lineages within a species. 
To study this, we applied seven environmental phages which we classified into 
two similarity groups (phA and phB) each consisting of three phages according to 
their lysis phenotypes. These phages do differ significantly in their lysis behaviour 
across the ecc groups. This is not only the case for the sum of all phages, but also 
for the individual phage groups phA and phB (Table 5). In our quest to get a first 
insight into the nature of this observation, we determined the serotype composition of 
the ecc groups. The type of O-antigen lipopolysaccharid structure of cell membranes, 
which is determinative for the serotype, often also serves as specific receptor for 
phages Yokota (Yokota et al., 1994). We observed that the ecc groups showed 
characteristic and different serotype composition (Fig. 8). Particularly eccB is 
characterized by a rather different serogroups composition compared to the other 
groups. Additionally, we observed that the type of the serogroup was somewhat 
predictive for the lysis success, ranging from being susceptible to all phages 
(serotype 3) to providing resistance to phage attack (serotype 4, 7, 8) (see 
Supplemental material, Fig. 9). The consolidation of the results from genetic structure 
(Fig. 1), serotype composition of ecc groups (Fig. 8) and the lysis susceptibility 
characteristics of serotypes (see Supplemental material, Fig. 9) suggest a 
 51
5. Discussion 
mechanism which may explain the differential lysis phenotype of the phages on ecc 
groups. Though this might be mostly the case for the environmental populations of P. 
aeruginosa, as clinical strains, especially the ones that induce chronic infections, 
tend to change their lipopolysaccharide profile in the direction of gaining 
polyagglutination, autoagglutination and “no agglutination” phenomena (Hancock et 
al., 1983; Pitt et al., 1986). Furthermore, these results suggest phages to contribute 
by their distinguishing lysis phenotype to the inner cohesion of the ecc and thereby to 
the further cladogenesis within P. aeruginosa.  
Another interesting feature is the observation that the clinical strains obviously 
become more susceptible to phage lysis, irrespective of the individual phages and 
ecc group. The molecular reason for this is currently unclear. The here observed 
larger susceptibility of clinical strains nourishes the hope of successful application of 
phages in phage therapy (Debarbieux et al., 2010; McVay et al., 2007; Merabishvili et 
al., 2009; Thiel, 2004; Watanabe et al., 2007). 
 
5.3. Natural environment versus clinics: Which habitat has a greater impact on 
the microevolutionary dynamics in P. aeruginosa? 
Numerous studies, including ours, have shown that in general representatives 
from all genetic lineages of P. aeruginosa are found both in the environmental and 
clinical habitat (Alonso et al., 1999; Kiewitz & Tummler, 2000; Morales et al., 2004; 
Ruimy et al., 2001). There may be very few exceptions, such as the MDR serotype 
0:12 lineage, which has not yet been found in environmental samples. Numerous 
studies have also shown that P. aeruginosa strains may substantially change 
genetically and phenotypically the longer they reside in the clinic habitat (which is set 
here equivalent to animal or human bodies). The dominance of studies with a clinical 
motivation reflects our interest in P. aeruginosa due to its threat as severe 
opportunistic human pathogen. Nevertheless, leaving our anthropocentric interest in 
P. aeruginsa aside for a while, the question is justified whether the clinical habitat or 
the natural environment has a larger influence on the evolution of P. aeruginosa.  
We argue here that the natural environment is probably far more important for the 
microevolutionary dynamics in P. aeruginosa than the clinical habitat. In order to 
discuss this, it is important to reflect census population sizes, selection pressures 
and the migrational move between environmental and clinical habitats. 
First, it is reasonable to assume that the fraction of P. aeruginosa cells residing in 
the clinical habitat is rather tiny compared to the environment. Only a few individuals 
from the humans and other animals are being infected, either via environmental or 
nosocomial sources and probably not all P. aeruginosa cells from a dead human 
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body will return to the environment again. In contrast, it appears as if P. aeruginosa is 
present in all sorts of non-extreme environmental water sources (Ahlen et al., 1998; 
Khan et al., 2007; Mena & Gerba, 2009; Pellett et al., 1983; Pirnay et al., 2005; 
Romling et al., 2005). Taking into account the vast amount of environmental water 
bodies, the census environmental population size is probably far larger than the 
clinics population size.  
Second, in order for the clinical habitat to have a substantial impact on the global 
population of P. aeruginosa, it would first be necessary for the clinical strains to (i) 
return back into the environmental habitat again, and to (ii) then successfully replace 
native environmental strains. For the latter, this would necessitate clinical strains to 
gain, via evolutionary change in the infected animal body, those phenotypes which 
might then confer a selective advantage in the environmental habitats. We have 
studied here several phenotypes in comparison of clinical and environmental strains. 
As a general observation, clinical strains tend to loose or weaken environmentally 
relevant abilities as a result of the clinical habitat, such as proteolytic activity and 
several motility phenotypes. Other phenotypes, such as pyocyanin production, did 
not change. Interestingly, we observed for a subset of clinical strains a tendency to 
perform larger biofilms. Biofilms are since long known to be a defence mechanism, 
as biofilms provide an orders of magnitude larger resistance to antiobiotics than in 
planctonic cells (Lewis et al., 2005; Lewis, 2001). The potential enlargement of 
biofilm formation could be of adaptive advantage in the environment. However, in 
some instances, biofilms may also readily be destroyed by phages (Hughes et al., 
1998; Knezevic & Petrovic, 2008; Lewis, 2001; Suthereland et al., 2004), therefore 
an increased biofilm formation ability might not necessarily convey a selective 
advantage. Beyond the results presented here, as has nicely been compiled by Ciofu 
et al (Ciofu et al., 2010), further mutational changes in clinical isolates (mostly CF) 
are increased alginate production and occurrence of mucoid variants (Govan & 
Nelson, 1993), loss of quorum sensing (D'Argenio et al., 2007; Smith et al., 2006a), 
loss of motility (Mahenthiralingam et al., 1994), loss of effector proteins of the type III 
secretion system (Jain et al., 2004), loss of the O-antigen components of the 
lipopolysaccharide (Hancock et al., 1983), reduced virulence (Luzar & Montie, 1985), 
reduced capacity for in vitro biofilm formation (Lee et al., 2005) (though this contrasts 
with our observations, Fig. 5) and increased antibiotic resistance (Ciofu et al., 2001). 
Thus, our own observations and insights from literature indicate that evolutionary 
changes of P. aeruginosa in clinical habitats are mainly associated with losses of 
phenotypes due to the specialisation to the human habitat. Moreover, our studies 
indicate that these phenotypic changes affect all ecc groups more or less equal. It 
can therefore be assumed that the return of clinically adapted P. aeruginosa into the 
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ruggedness of natural habitats is associated with negative selection and therefore a 
decreased potential to successfully replace the far more abundant native 
environmental clones.  
In sum, we do argue here that the environmental habitat is the major habitat 
shaping the population structure of P. aeruginosa (Khan et al., 2007). The previous 
mainly clinically based population genetic studies probably simply reflect the genetic 
structure present, and shaped by, the natural environment. Among the epidemic 
clones discussed, probably only very few may be indeed epidemic in a clinical sense 
(see WHO definition). A typical example for this might be the MDR serotype O12 
clone (Patzer & Dzierzanowska, 1994; Talarmin et al., 1996; Watine, 1999). The 
relative abundance of clone C in the clinical habitat, however, may simply reflect the 
observation that clone C is also a very abundant clone in aquatic habitats, but may 
perhaps not be a typically epidemic clone.  
We therefore suppose that P. aeruginosa mainly evolves in the natural 
environment and that clinically triggered evolutionary changes play only a minor role 
in the global evolution of P. aeruginosa. 
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Figure 6a. Pairwise comparison of joint host specificity of phages. On the x-axes 
names of the paired phages are given: 3 (JG003), 4 (JG004), 5 (JG005), 24 (JG024), 25 (JG025), 26 
(JG026) and 28 (JG028). 
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Figure 9. Distribution of lysis efficiencies of the 7 phages across different 
serotypes. The proportions (%) of the lysis phenotypes for individual phages among all strains with a 
given serotype are shown as black (clear lysis), striped (semi lysis) or white (no lysis) bars. The results 
from serotype 7 and 8 are summed up, as these serotypes are frequently not distinguishable. The 
grey field in the background indicates the average value from the combined data of all phages. The 
data are based on the combined set of 99 environmental and 96 clinical strains.  
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Figure 10. Geographical localization of the 13 sampling places along Lower Saxony 
rivers. 
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Figure 11. The structure of the genetic relationships among the P. aeruginosa host 
strains as based on eBURST analysis of the core genome SNP pattern. This figure is 
effectively the same eBURST graph as shown in Figure 1, with the difference that in this figure the 
names of all clones are given. Pink clone names are represented by both clinical and environmental 
strains. Uniquely clinical or environmental clones are coloured in green or in black, respectively. The 
founder strain of the clonal complexes is shown as a blue spot. 
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Different colors represent different water qualities (greenish = low polluted, yellowish = moderately 
polluted, pinkish = strongly polluted); “-w” denotes winter, “-s” denotes summer. 
 
 
Different colors represent different water qualities (greenish = low polluted, yellowish = moderately 
polluted, pinkish = strongly polluted) also “-w” denotes winter, “-s” denotes summer. 
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Different colors represent different water qualities (greenish = low polluted, yellowish = moderately 
polluted, pinkish = strongly polluted); “-w” denotes winter, “-s” denotes summer. 
 
 
Different colors represent different water qualities (greenish = low polluted, yellowish = moderately 
polluted, pinkish = strongly polluted); “-w” denotes winter, “-s” denotes summer. 
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Different colors represent different water qualities (greenish = low polluted, yellowish = moderately 
polluted, pinkish = strongly polluted); “-w” denotes winter, “-s” denotes summer. 
 
 
Different colors represent different water qualities (greenish = low polluted, yellowish = moderately 
polluted, pinkish = strongly polluted); “-w” denotes winter, “-s” denotes summer. 
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Different colors represent different water qualities (greenish = low polluted, yellowish = moderately 
polluted, pinkish = strongly polluted); “-w” denotes winter, “-s” denotes summer. 
 
 
Figure 12. Detailed list of the haplotypes’ sampling abundancies in every each 
sampling station, both seasons. 
 
 
Supplemental Table 1. Categories of water load concentrations for ten chemical substance 
groups as defined by the Lower Saxony (Germany) Ministry of the Environment: class I (no load), 
class I-II (very minor), class II (minor, which is the target-setting by the Ministry) ), class II-III (moderate 
to substantial), class III (substantial), class III-IV (strong), class IV (very strong). With the exception for 
AOX (µg/l), all concentrations are given in mg per liter. 
 
 class  I 
class  
I-II  
class  
II  
class  
II-III  
class  
III  
class  
III-IV) 
class  
IV  
Total 
nitrogen < 1 < 1.5 < 3 < 6 < 12 < 24 > 24 
Ammonium < 0.04 < 0.1 < 0.3 < 0.6 < 1.2 < 2.4 > 2.4 
Nitrate < 1 < 1.5 < 2.5 < 5 < 10 < 20 > 20 
Nitrite < 0.01 < 0.05 < 0.1 < 0.2 < 0.4 < 0.8 > 0.8 
AOX < 0  < 10 < 25 < 50 < 100 < 200 > 200 
Phosphate < 0.02 < 0.04 < 0.1 < 0.2 < 0.4 < 0.8 > 0.8 
Sulfate < 25 < 50 < 100 < 200 < 400 < 800 > 800 
TOC < 2 < 3 < 5 < 10 < 20 < 40 > 40 
Total 
phosphate < 0.05 < 0.08 < 0.15 < 0.3 < 0.6 < 1.2 > 1.2 
Chloride < 25 < 50 < 100 < 200 < 400 < 800 > 800 
 
AOX - adsorbable organic halogen compounds 
TOC - total organic carbon  
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Supplemental Table 2. Detailes on the names, genotypic characteristics, geographical and ecological backgroud of the P. aeruginosa strains. 
Strain Hexadecimal code Haplotype Origin Source Additional Info Location Date Country 
A 5803 F429 I Airway (Wiehlmann et al., 2007) unk Heidelberg 1992 Germany 
245 1BAE E Animal (Khan et al., 2007) Dolphin Japan May-03 Japan 
DSM 939 049A S13 animal water (Wiehlmann et al., 2007) bottle unk bef. 1969 unk 
892 3C52 K Burn wound (Wiehlmann et al., 2007) Int.care unit Hannover 1990 Germany 
PA14 D421  burnwound (Wiehlmann et al., 2007) unk Boston unk USA 
H2 241A S20 catheter (Wiehlmann et al., 2007) unk unk unk unk 
4 F469 D CF (Wiehlmann et al., 2007) throat swab Hannover 1998 Germany 
11 149A E33 CF (Wiehlmann et al., 2007) throat swab Hannover 1998 Germany 
12 239A L CF (Wiehlmann et al., 2007) throat swab Hannover 1998 Germany 
14 6C1A S CF (Wiehlmann et al., 2007) throat swab Hannover 1998 Germany 
21 EC29 J1 CF (Wiehlmann et al., 2007) throat swab Hannover 1998 Germany 
36 E479 E46 CF (Wiehlmann et al., 2007) throat swab Hannover 1998 Germany 
54 F46A D1 CF (Wiehlmann et al., 2007) throat swab Hannover 1999 Germany 
56 2C22 E27 CF (Wiehlmann et al., 2007) throat swab Hannover 1999 Germany 
69 E022 E17 CF (Wiehlmann et al., 2007) throat swab Hannover unk Germany 
70 2C2A E71 CF (Wiehlmann et al., 2007) throat swab Hannover 1999 Germany 
125 6C2A P CF (Wiehlmann et al., 2007) throat swab Hannover Jan-01 Germany 
126 F429 I CF (Wiehlmann et al., 2007) throat swab Hannover Jan-01 Germany 
128 EA0A A3 CF (Wiehlmann et al., 2007) throat swab Hannover Feb-01 Germany 
247 C40A C CF (Wiehlmann et al., 2007) throat swab Hannover Jun-02 Germany 
252 C40A C CF (Wiehlmann et al., 2007) throat swab Hannover Dec-03 Germany 
265 0812 V CF (Wiehlmann et al., 2007) throat swab Hannover Nov-03 Germany 
278 6C22 Y CF (Wiehlmann et al., 2007) throat swab Hannover Jun-03 Germany 
321 3C2A U CF (Wiehlmann et al., 2007) throat swab Hannover unk Germany 
323 E429 B CF (Wiehlmann et al., 2007) throat swab Hannover Jun-03 Germany 
345 4C12 T CF (Wiehlmann et al., 2007) throat swab Hannover Feb-03 Germany 
362 EA0A A3 CF (Wiehlmann et al., 2007) throat swab Hannover Jul-08 Germany 
404 0812 V CF (Wiehlmann et al., 2007) throat swab Hannover Sep-04 Germany 
424 2F82 S7 CF (Wiehlmann et al., 2007) throat swab Hannover Sep-04 Germany 
433 2C22 E27 CF (Wiehlmann et al., 2007) throat swab Hannover unk Germany 
483 0BA2 E31 CF (Wiehlmann et al., 2007) throat swab Hannover unk Germany 
63741 3C52 K CF (Wiehlmann et al., 2007) throat swab Hannover Jan-02 Germany 
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Strain Hexadecimal code Origin Source Additional Info Location Date Country Strain 
172-5645 741E E9 CF (Wiehlmann et al., 2007) throat swab Hannover Mar-02 Germany 
188-5064 F421 A2 CF (Wiehlmann et al., 2007) throat swab Hannover Jul-02 Germany 
195-5050 D421 A CF (Wiehlmann et al., 2007) throat swab Hannover Nov-02 Germany 
212-5826 D421 A CF (Wiehlmann et al., 2007) Sputum Kopenhagen 1992 Denmark 
2733/92 3C2A U CF (Wiehlmann et al., 2007) Sputum Kopenhagen 1992 Denmark 
2813 A/92 4012 O CF (Wiehlmann et al., 2007) throat swab Hannover Sep-05 Germany 
491-5530 EC2A J CF (Wiehlmann et al., 2007) Sputum Hannover 1983 Germany 
BST 1 E469 S52 CF (Wiehlmann et al., 2007) throat swab Hannover 1985 Germany 
CHA EC2A J CF (Wiehlmann et al., 2007) throat swab Grenoble unk France 
DM E84A S1 CF (Wiehlmann et al., 2007) Sputum Hamburg 1984 Germany 
G7 6D92 H CF (Wiehlmann et al., 2007) Sputum Stade 1986 Germany 
K9 1BAE E CF (Wiehlmann et al., 2007) Sputum Husum 1985 Germany 
KB1 059A S16 CF (Wiehlmann et al., 2007) throat swab Bremen 1987 Germany 
LES400 4C12 T CF (Wiehlmann et al., 2007) throat swab Liverpool unk Great Britain 
MF 6 AC9A S10 CF (Wiehlmann et al., 2007) throat swab Bremen 1987 Germany 
PD 1 E59A S47 CF (Wiehlmann et al., 2007) throat swab Hannover 1985 Germany 
RN 4 D421 A CF (Wiehlmann et al., 2007) throat swab Oldenburg 1986 Germany 
RP 1 0C2E G CF (Wiehlmann et al., 2007) throat swab Hannover 1985 Germany 
SG1 (= C) C40A C CF (Wiehlmann et al., 2007) throat swab Bueckeburg 1986 Germany 
SS 1 6D92 H CF (Wiehlmann et al., 2007) throat swab Lueneburg 1985 Germany 
TBCF10839 3C52 K CF (Wiehlmann et al., 2007) throat swab Hannover 1983 Germany 
Va 24437 3C51 K1 CF (Wiehlmann et al., 2007) Sputum Halle 1992 Germany 
Va 26232 EC2A J CF (Wiehlmann et al., 2007) Sputum Halle 1992 Germany 
Va 27081 081E A8 CF (Wiehlmann et al., 2007) Sputum Halle 1992 Germany 
Va 27260 239A L CF (Wiehlmann et al., 2007) Sputum Halle 1992 Germany 
ZW 102 2E12 S26 CF (Wiehlmann et al., 2007) throat swab Leuven 1997 Belgium 
ZW 113 6E12 M CF (Wiehlmann et al., 2007) throat swab Rotterdam 1997 Netherlands 
ZW 117 0812 V CF (Wiehlmann et al., 2007) throat swab Vienna 1997 Austria 
ZW 119 F469 D CF (Wiehlmann et al., 2007) throat swab Posen 1997 Poland 
ZW 30 B420 B30 CF (Wiehlmann et al., 2007) throat swab Innsbruck 1997 Austria 
ZW 31 AC2E S48 CF (Wiehlmann et al., 2007) throat swab Innsbruck 1997 Austria 
ZW 41 0192 S14 CF (Wiehlmann et al., 2007) throat swab Verona 1997 Italy 
ZW 43 3C52 K CF (Wiehlmann et al., 2007) throat swab Genua 1997 Italy 
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Strain Hexadecimal code Origin Source Additional Info Location Date Country Strain 
ZW 49 A5AA S46 CF (Wiehlmann et al., 2007) throat swab Verona 1997 Italy 
ZW 54 6C12 S42 CF (Wiehlmann et al., 2007) throat swab Milano 1997 Italy 
ZW 64-1 279A S22 CF (Wiehlmann et al., 2007) throat swab Lund 1997 Sweden 
ZW 77 4012 O CF (Wiehlmann et al., 2007) throat swab London 1997 UK 
ZW 79 0C2E G CF (Wiehlmann et al., 2007) throat swab Galway 1997 Ireland 
ZW 81 D429 Q CF (Wiehlmann et al., 2007) throat swab London 1997 UK 
ZW 83 6E12 M CF (Wiehlmann et al., 2007) throat swab London 1997 UK 
ZW 85 D421 A CF (Wiehlmann et al., 2007) throat swab Aberdeen 1997 UK 
ZW 88 2C1A F CF (Wiehlmann et al., 2007) throat swab London 1997 UK 
ZW 92 EC22 S8 CF (Wiehlmann et al., 2007) throat swab Marseille 1997 France 
ZW 98a E419 S57 CF (Wiehlmann et al., 2007) throat swab Den Haag 1997 Netherlands 
1303 CC28 E54 Coastal (Khan et al., 2007) Kuroshio Japan Jun-03 Japan 
963 2C1A F Coastal (Khan et al., 2007) Tokyo Japan May-03 Japan 
242 0C2E G Coastal (Khan et al., 2007) Sagami Japan May-03 Japan 
243 0C2E G Coastal (Khan et al., 2007) Sagami Japan May-03 Japan 
601 0C2E G Coastal (Khan et al., 2007) Kumamoto Japan Dec-03 Japan 
54 049A S13 Coastal (Khan et al., 2007) Suruga Japan Mar-04 Japan 
60 049A S13 Coastal (Khan et al., 2007) Suruga Japan Mar-04 Japan 
M70A.2 0F9E A7 Faeces (Vives-Flórez & Garnica, 2006) unk Colombia unk Colombia 
M86A.1 0F9A E42 Faeces (Vives-Flórez & Garnica, 2006) unk Colombia 2006 Colombia 
M87A.1 0F9A E42 Faeces (Vives-Flórez & Garnica, 2006) unk Colombia 2006 Colombia 
M82A.3 AC9A S10 Faeces (Vives-Flórez & Garnica, 2006) unk Colombia unk Colombia 
ATCC 33356 CD9E S55 Faeces (Wiehlmann et al., 2007) unk Heidelberg 1965 Germany 
1540 8E9A E21 Freshwater (Khan et al., 2007) Zenpukujii Japan Sep-03 Japan 
1549 8E9A E21 Freshwater (Khan et al., 2007) Zenpukujii Japan Sep-03 Japan 
1563 3C1A E51 Freshwater (Khan et al., 2007) Tamako Japan Sep-03 Japan 
p6_1 4C8E E68 Freshwater Claudia Scotta  fountain  Majorca Jun-08 Spain 
p6_3 4C8E E68 Freshwater Claudia Scotta  fountain  Majorca Jun-08 Spain 
p6_2 6E0A E69 Freshwater Claudia Scotta  fountain  Majorca Jun-08 Spain 
p4_2 B42A E70 Freshwater Claudia Scotta  fountain  Majorca Jun-08 Spain 
p4_3 B42A E70 Freshwater Claudia Scotta  fountain  Majorca Jun-08 Spain 
ATCC 33988 6C22 Y fuel tank (Wiehlmann et al., 2007) Ponca City Oklahoma unk USA 
28 EA0A A3 G. c. aquifer (Foght et al., 1996) Aq 8 USA 1987 USA 
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Strain Hexadecimal code Origin Source Additional Info Location Date Country Strain 
29 EA0A A3 G. c. aquifer (Foght et al., 1996) Aq 8 USA 1987 USA 
30 EA0A A3 G. c. aquifer (Foght et al., 1996) Aq 8 USA 1987 USA 
31 EA0A A3 G. c. aquifer (Foght et al., 1996) Aq 8 USA 1987 USA 
32 EA0A A3 G. c. aquifer (Foght et al., 1996) Aq 8 USA 1987 USA 
33 EA0A A3 G. c. aquifer (Foght et al., 1996) Aq 8 USA 1987 USA 
35 EA0A A3 G. c. aquifer (Foght et al., 1996) Aq 8 USA 1987 USA 
36 EA0A A3 G. c. aquifer (Foght et al., 1996) Aq 2 USA 1987 USA 
38 EA0A A3 G. c. aquifer (Foght et al., 1996) Aq 2 USA 1987 USA 
40 EA0A A3 G. c. aquifer (Foght et al., 1996) Aq 8 USA 1987 USA 
41 EA0A A3 G. c. aquifer (Foght et al., 1996) Aq 8 USA 1987 USA 
PAK 55AA S39 laboratory (Wiehlmann et al., 2007) unk unk bef. 1960 Japan 
M28A.1 4C12 T Manure (Vives-Flórez & Garnica, 2006) unk Colombia unk Colombia 
1155 E429 B Open Ocean (Khan et al., 2007) Ocean Japan Jun-03 Japan 
1187 E429 B Open Ocean (Khan et al., 2007) Ocean Japan Jun-03 Japan 
1200 E429 B Open Ocean (Khan et al., 2007) Ocean Japan Jun-03 Japan 
1206 E429 B Open Ocean (Khan et al., 2007) Ocean Japan Jun-03 Japan 
100 EC21 E52 Open Ocean (Khan et al., 2007) Ocean Japan Mar-04 Japan 
DSM 1128 EC38 S32 Patient (Wiehlmann et al., 2007) ear infect. unk unk unk 
206 4C23 E53 River water (Khan et al., 2007) Arakawa Japan May-03 Japan 
1508 3C2A U River water (Khan et al., 2007) Arakawa Japan Nov-03 Japan 
JeDePA E661 E40 Soil unk unk India unk India 
M41A.1 478A E41 Soil (Vives-Flórez & Garnica, 2006) unk Colombia unk Colombia 
M9A.1 2C0A E44 Soil (Vives-Flórez & Garnica, 2006) Capachos Colombia unk Colombia 
M15A.3 EFAE E45 Soil (Vives-Flórez & Garnica, 2006) St. Marta Colombia unk Colombia 
BTX28A 2C2A E71 Soil (Vives-Flórez & Garnica, 2006) unk Colombia unk Colombia 
M19A.1 6C22 Y Soil (Vives-Flórez & Garnica, 2006) Garzas Colombia unk Colombia 
ATCC 10145 46BA S38 type strain (Wiehlmann et al., 2007) unk unk 1963 Czehoslovak. 
ATCC 33348 2C1A F unk (Wiehlmann et al., 2007) unk unk bef. 1980 Germany 
ATCC 33364 E42A B unk (Wiehlmann et al., 2007) unk unk 1982 unk 
DSM 1253 0B92 X unk (Wiehlmann et al., 2007) unk Stanford 1949 USA 
DSM 288 0B92 X unk (Wiehlmann et al., 2007) Hygiene inst. Goettingen 1990 Germany 
Gr 2057 2C92 S31 unk (Wiehlmann et al., 2007) unk Athens 1995 Greece 
Gr 2052 2C92 S31 unk (Wiehlmann et al., 2007) unk Athens 1995 Greece 
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Strain Hexadecimal code Origin Source Additional Info Location Date Country Strain 
Gr 2248 6D92 H unk (Wiehlmann et al., 2007) unk Athens 1995 Greece 
HJ2 0C2E G unk (Wiehlmann et al., 2007) Sputum Cologne 1990 Germany 
429SF6 2C9A E49 Water This study W  Ströhen Jul-08 Germany 
110E8 D421 A Water This study O/A  Groß Schwülp. Oct-07 Germany 
110B13 F661 A1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
114SE1 4C2E A11 Water This study O/A  Börßum Jul-08 Germany 
055E6 F421 A2 Water This study W Hessisch Oldend. Oct-07 Germany 
012SD1 EA0A A3 Water This study W Hann. Münden Jul-08 Germany 
120D11 85AA A4 Water This study O/A   Peine Oct-07 Germany 
012B5 7C2E A5 Water This study W Hann. Münden Oct-07 Germany 
702SC1 E429 B Water This study UW Langwedel Jul-08 Germany 
120SD3 B420 B30 Water This study O/A   Peine Jul-08 Germany 
120SF7 B021 B31 Water This study O/A   Peine Jul-08 Germany 
010SB1 C40A C Water This study O/A  Goslar Jul-08 Germany 
110E7 F469 D Water This study O/A  Groß Schwülp. Oct-07 Germany 
406E1 F46A D1 Water This study W Drakenburg Oct-07 Germany 
110B2 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
406B1 8D9A E10 Water This study W Drakenburg Oct-07 Germany 
429C2 B020 E11 Water This study W  Ströhen Oct-07 Germany 
120SE7 CF92 E12 Water This study O/A   Peine Jul-08 Germany 
429C4 4E22 E13 Water This study W  Ströhen Oct-07 Germany 
406C1 CC9A E14 Water This study W Drakenburg Oct-07 Germany 
120B3 AE1A E15 Water This study O/A   Peine Oct-07 Germany 
429C1 FD82 E16 Water This study W  Ströhen Oct-07 Germany 
429E4 E022 E17 Water This study W  Ströhen Oct-07 Germany 
702D4 885A E18 Water This study UW Langwedel Oct-07 Germany 
702F3 FC4A E19 Water This study UW Langwedel Oct-07 Germany 
110D1 081A E2 Water This study O/A  Groß Schwülp. Oct-07 Germany 
120SF3 6E1A E20 Water This study O/A   Peine Jul-08 Germany 
924SE4 6D9A E22 Water This study UW Brake-Sieltief Jul-08 Germany 
110SB6 8E9A E21 Water This study O/A  Groß Schwülp. Jul-08 Germany 
401F1 062E E24 Water This study W Allerbruch Oct-07 Germany 
706B1 282A E23 Water This study O/A  Celle Oct-07 Germany 
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110F3 4822 E25 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110B14 05AA E26 Water This study O/A  Groß Schwülp. Oct-07 Germany 
012A2 2C22 E27 Water This study W Hann.Münden Oct-07 Germany 
012D3 0C1E E28 Water This study W Hann.Münden Oct-07 Germany 
055E11 499A E32 Water This study W Hessisch Oldend. Oct-07 Germany 
902C1 4B9A E3 Water This study UW Brake-Weser Oct-07 Germany 
055F1 E422 E30 Water This study W Hessisch Oldend. Oct-07 Germany 
055C1 0BA2 E31 Water This study W Hessisch Oldend. Oct-07 Germany 
055E7 499A E32 Water This study W Hessisch Oldend. Oct-07 Germany 
120SB2 149A E33 Water This study O/A   Peine Jul-08 Germany 
114A2 A99A E34 Water This study O/A  Börßum Oct-07 Germany 
120E2 E421 E35 Water This study O/A   Peine Oct-07 Germany 
120E9 E99A E36 Water This study O/A   Peine Oct-07 Germany 
120D8 659A E37 Water This study O/A   Peine Oct-07 Germany 
012B2 259A E38 Water This study W Hann.Münden Oct-07 Germany 
110SE2 002A E39 Water This study O/A  Groß Schwülp. Jul-08 Germany 
706D1 EF9A E4 Water This study O/A  Celle Oct-07 Germany 
120SC3 0F9A E42 Water This study O/A   Peine Jul-08 Germany 
924SE1 2E1A E47 Water This study UW Brake-Sieltief Jul-08 Germany 
012SF1 2C9A E49 Water This study W Hann. Münden Jul-08 Germany 
120SD1 0C92 E5 Water This study O/A   Peine Jul-08 Germany 
055SE4 0D9E E55 Water This study W Hess. Oldendorf Jul-08 Germany 
110SA1 AFBA E56 Water This study O/A  Groß Schwülp. Jul-08 Germany 
110SB4 262A E57 Water This study O/A  Groß Schwülp. Jul-08 Germany 
055SE2 EC12 E58 Water This study W Hess. Oldendorf Jul-08 Germany 
055SD3 F46A D1 Water This study W Hess. Oldendorf Jul-08 Germany 
114SB4 D469 E6 Water This study O/A  Börßum Jul-08 Germany 
702SE1 6822 E60 Water This study UW Langwedel Jul-08 Germany 
110SA3 6BAE E63 Water This study O/A  Groß Schwülp. Jul-08 Germany 
702SD3 679E E61 Water This study UW Langwedel Jul-08 Germany 
110SB3 0E9A E62 Water This study O/A  Groß Schwülp. Jul-08 Germany 
902SA4 0322 E65 Water This study UW Brake-Weser Jul-08 Germany 
706SA2 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
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902SD3 B411 E66 Water This study UW Brake-Weser Jul-08 Germany 
902SE1 E82E E67 Water This study UW Brake-Weser Jul-08 Germany 
120SE2 82BA E7 Water This study O/A   Peine Jul-08 Germany 
110SA2 2C2A E71 Water This study O/A  Groß Schwülp. Jul-08 Germany 
902F1 E41B E73 Water This study UW Brake-Weser Oct-07 Germany 
120B5 F49B E8 Water This study O/A   Peine Oct-07 Germany 
055SD1 741E E9 Water This study W Hess. Oldendorf Jul-08 Germany 
110SF5 2C1A F Water This study O/A  Groß Schwülp. Jul-08 Germany 
429E5 0C2E G Water This study W  Ströhen Oct-07 Germany 
406A2 6D92 H Water This study W Drakenburg Oct-07 Germany 
120SF5 F429 I Water This study O/A   Peine Jul-08 Germany 
120SD2 EC2A J Water This study O/A   Peine Jul-08 Germany 
110SC1 EC29 J1 Water This study O/A  Groß Schwülp. Jul-08 Germany 
114SC1 3C52 K Water This study O/A  Börßum Jul-08 Germany 
012SC1 239A L Water This study W Hann. Münden Jul-08 Germany 
110E6 6E12 M Water This study O/A  Groß Schwülp. Oct-07 Germany 
114SB3 6C2A P Water This study O/A  Börßum Jul-08 Germany 
012SE1 6C1A S Water This study W Hann. Münden Jul-08 Germany 
429A2 E84A S1 Water This study W  Ströhen Oct-07 Germany 
924SF5 0D9A S19 Water This study UW Brake-Sieltief Jul-08 Germany 
706SC3 2C12 S27 Water This study O/A  Celle Jul-08 Germany 
406SF1 2C2E S29 Water This study W Drakenburg Jul-08 Germany 
702SF2 0C1A S3 Water This study UW Langwedel Jul-08 Germany 
114SA7 2FAA S35 Water This study O/A  Börßum Jul-08 Germany 
702E1 6CA2 S4 Water This study UW Langwedel Oct-07 Germany 
012SC3 841E S44 Water This study W Hann. Münden Jul-08 Germany 
902SB4 4992 S5 Water This study UW Brake-Weser Jul-08 Germany 
924SB3 EC22 S8 Water This study UW Brake-Sieltief Jul-08 Germany 
110SD4 CD9E S55 Water This study O/A  Gross Schw Jul-08 Germany 
120A1 8C2A S6 Water This study O/A   Peine Oct-07 Germany 
120F4 2F82 S7 Water This study O/A   Peine Oct-07 Germany 
429D2 4C12 T Water This study W  Ströhen Oct-07 Germany 
012E6 882A S9 Water This study W Hann.Münden Oct-07 Germany 
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120D6 3C2A U Water This study O/A   Peine Oct-07 Germany 
429SC1 0812 V Water This study W  Ströhen Jul-08 Germany 
120SA2 6C22 Y Water This study O/A   Peine Jul-08 Germany 
012D2 D421 A Water This study W Hann.Münden Oct-07 Germany 
012F10 D421 A Water This study W Hann.Münden Oct-07 Germany 
055F5 D421 A Water This study W Hessisch Oldend. Oct-07 Germany 
055F6 D421 A Water This study W Hessisch Oldend. Oct-07 Germany 
120B6 D421 A Water This study O/A   Peine Oct-07 Germany 
012SA1 D421 A Water This study W Hann. Münden Jul-08 Germany 
503 D421 A Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
114D1 F421 A2 Water This study O/A  Börßum Oct-07 Germany 
055SA1 F421 A2 Water This study W Hess. Oldendorf Jul-08 Germany 
506 F421 A2 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
012E2 EA0A A3 Water This study W Hann.Münden Oct-07 Germany 
055B1 EA0A A3 Water This study W Hessisch Oldend. Oct-07 Germany 
055E10 EA0A A3 Water This study W Hessisch Oldend. Oct-07 Germany 
055F4 EA0A A3 Water This study W Hessisch Oldend. Oct-07 Germany 
110B6 EA0A A3 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110B9 EA0A A3 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110D12 EA0A A3 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110E2 EA0A A3 Water This study O/A  Groß Schwülp. Oct-07 Germany 
114B1 EA0A A3 Water This study O/A  Börßum Oct-07 Germany 
114D2 EA0A A3 Water This study O/A  Börßum Oct-07 Germany 
114E1 EA0A A3 Water This study O/A  Börßum Oct-07 Germany 
702A1 EA0A A3 Water This study UW Langwedel Oct-07 Germany 
702F1 EA0A A3 Water This study UW Langwedel Oct-07 Germany 
055E1 85AA A4 Water This study W Hessisch Oldend. Oct-07 Germany 
706C2 EA0A A3 Water This study O/A  Celle Oct-07 Germany 
012SE3 EA0A A3 Water This study W Hann. Münden Jul-08 Germany 
W15Aug30 EA0A A3 Water (Pirnay et al., 2005) Wlw Brussels 2001 Belgium 
012D1 85AA A4 Water This study W Hann.Münden Oct-07 Germany 
114F1 85AA A4 Water This study O/A  Börßum Oct-07 Germany 
055E2 85AA A4 Water This study W Hessisch Oldend. Oct-07 Germany 
 88
7. Appendix 
Strain Hexadecimal code Origin Source Additional Info Location Date Country Strain 
523 0F9E A7 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
055F2 E429 B Water This study W Hessisch Oldend. Oct-07 Germany 
406A1 E429 B Water This study W Drakenburg Oct-07 Germany 
513 E429 B Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
520 E429 B Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
055D2 B420 B30 Water This study W Hessisch Oldend. Oct-07 Germany 
055D3 B420 B30 Water This study W Hessisch Oldend. Oct-07 Germany 
055D4 B420 B30 Water This study W Hessisch Oldend. Oct-07 Germany 
055E3 B420 B30 Water This study W Hessisch Oldend. Oct-07 Germany 
055E5 B420 B30 Water This study W Hessisch Oldend. Oct-07 Germany 
110D9 B420 B30 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110E1 B420 B30 Water This study O/A  Groß Schwülp. Oct-07 Germany 
120C1 B420 B30 Water This study O/A   Peine Oct-07 Germany 
120D4 B420 B30 Water This study O/A   Peine Oct-07 Germany 
120D5 B420 B30 Water This study O/A   Peine Oct-07 Germany 
120D9 B420 B30 Water This study O/A   Peine Oct-07 Germany 
120D10 B420 B30 Water This study O/A   Peine Oct-07 Germany 
120E4 B420 B30 Water This study O/A   Peine Oct-07 Germany 
120E5 B420 B30 Water This study O/A   Peine Oct-07 Germany 
120F2 B420 B30 Water This study O/A   Peine Oct-07 Germany 
401D1 B420 B30 Water This study W Allerbruch Oct-07 Germany 
429E3 B420 B30 Water This study W  Ströhen Oct-07 Germany 
429F1 B420 B30 Water This study W  Ströhen Oct-07 Germany 
702E2 B420 B30 Water This study UW Langwedel Oct-07 Germany 
706F1 B420 B30 Water This study O/A  Celle Oct-07 Germany 
114SF4 B420 B30 Water This study O/A  Börßum Jul-08 Germany 
924D1 B420 B30 Water This study UW Brake-Sieltief Oct-07 Germany 
114SC3 B420 B30 Water This study O/A  Börßum Jul-08 Germany 
114SD2 B420 B30 Water This study O/A  Börßum Jul-08 Germany 
114SE2 B420 B30 Water This study O/A  Börßum Jul-08 Germany 
114SF1 B420 B30 Water This study O/A  Börßum Jul-08 Germany 
902SA3 B420 B30 Water This study UW Brake-Weser Jul-08 Germany 
902SA1 B420 B30 Water This study UW Brake-Weser Jul-08 Germany 
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902SB2 B420 B30 Water This study UW Brake-Weser Jul-08 Germany 
902SB3 B420 B30 Water This study UW Brake-Weser Jul-08 Germany 
902SC1 B420 B30 Water This study UW Brake-Weser Jul-08 Germany 
902SD1 B420 B30 Water This study UW Brake-Weser Jul-08 Germany 
902SD2 B420 B30 Water This study UW Brake-Weser Jul-08 Germany 
902SE3 B420 B30 Water This study UW Brake-Weser Jul-08 Germany 
902SF2 B420 B30 Water This study UW Brake-Weser Jul-08 Germany 
902SF3 B420 B30 Water This study UW Brake-Weser Jul-08 Germany 
902SF4 B420 B30 Water This study UW Brake-Weser Jul-08 Germany 
924SA3 B420 B30 Water This study UW Brake-Sieltief Jul-08 Germany 
924SB1 B420 B30 Water This study UW Brake-Sieltief Jul-08 Germany 
924SD2 B420 B30 Water This study UW Brake-Sieltief Jul-08 Germany 
924SD5 B420 B30 Water This study UW Brake-Sieltief Jul-08 Germany 
924SF3 B420 B30 Water This study UW Brake-Sieltief Jul-08 Germany 
924SF6 B420 B30 Water This study UW Brake-Sieltief Jul-08 Germany 
702SB3 B021 B31 Water This study UW Langwedel Jul-08 Germany 
702SF3 B021 B31 Water This study UW Langwedel Jul-08 Germany 
010A1 C40A C Water This study O/A  Goslar Oct-07 Germany 
010C1 C40A C Water This study O/A  Goslar Oct-07 Germany 
010D1 C40A C Water This study O/A  Goslar Oct-07 Germany 
010E1 C40A C Water This study O/A  Goslar Oct-07 Germany 
012D4 C40A C Water This study W Hann.Münden Oct-07 Germany 
012F8 C40A C Water This study W Hann.Münden Oct-07 Germany 
012F9 C40A C Water This study W Hann.Münden Oct-07 Germany 
010SD1 C40A C Water This study O/A  Goslar Jul-08 Germany 
110D4 C40A C Water This study O/A  Groß Schwülp. Oct-07 Germany 
702D3 C40A C Water This study UW Langwedel Oct-07 Germany 
902D1 C40A C Water This study UW Brake-Weser Oct-07 Germany 
010SA1 C40A C Water This study O/A  Goslar Jul-08 Germany 
010SB2 C40A C Water This study O/A  Goslar Jul-08 Germany 
010SC1 C40A C Water This study O/A  Goslar Jul-08 Germany 
010SE3 C40A C Water This study O/A  Goslar Jul-08 Germany 
010SE2 C40A C Water This study O/A  Goslar Jul-08 Germany 
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010SE4 C40A C Water This study O/A  Goslar Jul-08 Germany 
010SF2 C40A C Water This study O/A  Goslar Jul-08 Germany 
012SB1 C40A C Water This study W Hann. Münden Jul-08 Germany 
012SC2 C40A C Water This study W Hann. Münden Jul-08 Germany 
W5Aug28 C40A C Water (Pirnay et al., 2005) Wlw Brussels 2001 Belgium 
510 C40A C Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
114SA1 F469 D Water This study O/A  Börßum Jul-08 Germany 
W15Dec14 F469 D Water (Pirnay et al., 2005) Wlw Brussels 2001 Belgium 
429A1 F46A D1 Water This study W  Ströhen Oct-07 Germany 
429B1 F46A D1 Water This study W  Ströhen Oct-07 Germany 
702D1 F46A D1 Water This study UW Langwedel Oct-07 Germany 
902A1 F46A D1 Water This study UW Brake-Weser Oct-07 Germany 
902E3 F46A D1 Water This study UW Brake-Weser Oct-07 Germany 
924E1 F46A D1 Water This study UW Brake-Sieltief Oct-07 Germany 
055SF4 F46A D1 Water This study W Hess. Oldendorf Jul-08 Germany 
114SA2 F46A D1 Water This study O/A  Börßum Jul-08 Germany 
406SF3 F46A D1 Water This study W Drakenburg Jul-08 Germany 
702SA1 F46A D1 Water This study UW Langwedel Jul-08 Germany 
702SA2 F46A D1 Water This study UW Langwedel Jul-08 Germany 
702SB1 F46A D1 Water This study UW Langwedel Jul-08 Germany 
702SB2 F46A D1 Water This study UW Langwedel Jul-08 Germany 
702SE2 F46A D1 Water This study UW Langwedel Jul-08 Germany 
702SE3 F46A D1 Water This study UW Langwedel Jul-08 Germany 
110A5 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
702SSE5 F46A D1 Water This study UW Langwedel Jul-08 Germany 
702SF4 F46A D1 Water This study UW Langwedel Jul-08 Germany 
924SF7 F46A D1 Water This study UW Brake-Sieltief Jul-08 Germany 
508 F46A D1 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
512 F46A D1 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
110A2 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110A4 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110A8 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110A6 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
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110B1 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110B5 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110B7 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110B11 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110B12 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110C2 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110C4 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110D2 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110D11 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110E10 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110F5 CBA3 E1 Water This study O/A  Groß Schwülp. Oct-07 Germany 
924SA1 CBA3 E1 Water This study UW Brake-Sieltief Jul-08 Germany 
924SC2 CBA3 E1 Water This study UW Brake-Sieltief Jul-08 Germany 
429C3 B020 E11 Water This study W  Ströhen Oct-07 Germany 
706SA1 CC9A E14 Water This study O/A  Celle Jul-08 Germany 
429D1 AE1A E15 Water This study W  Ströhen Oct-07 Germany 
429E1 AE1A E15 Water This study W  Ströhen Oct-07 Germany 
110A3 081A E2 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110B8 081A E2 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110D8 081A E2 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110E3 081A E2 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110E4 081A E2 Water This study O/A  Groß Schwülp. Oct-07 Germany 
120E3 6E1A E20 Water This study O/A   Peine Oct-07 Germany 
110E9 081A E2 Water This study O/A  Groß Schwülp. Oct-07 Germany 
110F2 081A E2 Water This study O/A  Groß Schwülp. Oct-07 Germany 
114SA3 081A E2 Water This study O/A  Börßum Jul-08 Germany 
114SA4 081A E2 Water This study O/A  Börßum Jul-08 Germany 
114SD1 081A E2 Water This study O/A  Börßum Jul-08 Germany 
114SF3 081A E2 Water This study O/A  Börßum Jul-08 Germany 
120B2 6E1A E20 Water This study O/A   Peine Oct-07 Germany 
120D7 6E1A E20 Water This study O/A   Peine Oct-07 Germany 
702F2 6E1A E20 Water This study UW Langwedel Oct-07 Germany 
120F1 6E1A E20 Water This study O/A   Peine Oct-07 Germany 
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702D2 8E9A E21 Water This study UW Langwedel Oct-07 Germany 
110SB2 8E9A E21 Water This study O/A  Groß Schwülp. Jul-08 Germany 
110D3 6D9A E22 Water This study O/A  Groß Schwülp. Oct-07 Germany 
429SF1 6D9A E22 Water This study W  Ströhen Jul-08 Germany 
114D3 2C22 E27 Water This study O/A  Börßum Oct-07 Germany 
012SD2 2C22 E27 Water This study W Hann. Münden Jul-08 Germany 
516 2C22 E27 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
511 0C1E E28 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
055E9 499A E32 Water This study W Hessisch Oldend. Oct-07 Germany 
012E1 149A E33 Water This study W Hann.Münden Oct-07 Germany 
012E4 149A E33 Water This study W Hann.Münden Oct-07 Germany 
012E5 149A E33 Water This study W Hann.Münden Oct-07 Germany 
012F7 149A E33 Water This study W Hann.Münden Oct-07 Germany 
055F3 149A E33 Water This study W Hessisch Oldend. Oct-07 Germany 
110SF1 149A E33 Water This study O/A  Groß Schwülp. Jul-08 Germany 
W15Dec3 149A E33 Water (Pirnay et al., 2005) Wlw Brussels 2001 Belgium 
W15Dec2 149A E33 Water (Pirnay et al., 2005) Wlw Brussels 2001 Belgium 
518 149A E33 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
517 149A E33 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
114A1 A99A E34 Water This study O/A  Börßum Oct-07 Germany 
W5Aug16 259A E38 Water (Pirnay et al., 2005) Wlw Brussels 2001 Belgium 
519 2E1A E47 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
012F1 002A E39 Water This study W Hann.Münden Oct-07 Germany 
012F2 002A E39 Water This study W Hann.Münden Oct-07 Germany 
M8A.1 0F9A E42 Water (Vives-Flórez & Garnica, 2006) Cano Limon Colombia 2001 Colombia 
M8A.3 0F9A E42 Water (Vives-Flórez & Garnica, 2006) Cano Limon Colombia 2001 Colombia 
M8A.2 0F9A E42 Water (Vives-Flórez & Garnica, 2006) Cano Limon Colombia 2001 Colombia 
M8A.4 2822 E43 Water (Vives-Flórez & Garnica, 2006) Cano Limon Colombia 2001 Colombia 
524 E479 E46 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
499 E479 E46 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
525 2E1A E47 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
505 7C1A E50 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
497 C81A E48 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
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110SB5 AFBA E56 Water This study O/A  Groß Schwülp. Jul-08 Germany 
110SC2 AFBA E56 Water This study O/A  Groß Schwülp. Jul-08 Germany 
110SD2 262A E57 Water This study O/A  Groß Schwülp. Jul-08 Germany 
902SC4 262A E57 Water This study UW Brake-Weser Jul-08 Germany 
902E2 D469 E6 Water This study UW Brake-Weser Oct-07 Germany 
406SF2 6822 E60 Water This study W Drakenburg Jul-08 Germany 
406SF4 6822 E60 Water This study W Drakenburg Jul-08 Germany 
110SE3 0E9A E62 Water This study O/A  Groß Schwülp. Jul-08 Germany 
110SD3 0E9A E62 Water This study O/A  Groß Schwülp. Jul-08 Germany 
110SF7 0E9A E62 Water This study O/A  Groß Schwülp. Jul-08 Germany 
706SA3 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SB1 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SB2 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SB3 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SB4 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SC2 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SC4 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SD1 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SD2 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SD3 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
120B1 F49B E8 Water This study O/A   Peine Oct-07 Germany 
706SE1 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SE2 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SE4 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SE5 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SF1 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SF2 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
706SF3 4C1A E64 Water This study O/A  Celle Jul-08 Germany 
902SC2 0322 E65 Water This study UW Brake-Weser Jul-08 Germany 
902SC3 B411 E66 Water This study UW Brake-Weser Jul-08 Germany 
902SE2 B411 E66 Water This study UW Brake-Weser Jul-08 Germany 
120E7 F49B E8 Water This study O/A   Peine Oct-07 Germany 
120D3 F49B E8 Water This study O/A   Peine Oct-07 Germany 
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406D2 741E E9 Water This study W Drakenburg Oct-07 Germany 
406D3 741E E9 Water This study W Drakenburg Oct-07 Germany 
406D4 741E E9 Water This study W Drakenburg Oct-07 Germany 
507 2C1A F Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
012A1 0C2E G Water This study W Hann.Münden Oct-07 Germany 
012A4 0C2E G Water This study W Hann.Münden Oct-07 Germany 
012B3 0C2E G Water This study W Hann.Münden Oct-07 Germany 
012B4 0C2E G Water This study W Hann.Münden Oct-07 Germany 
012C1 0C2E G Water This study W Hann.Münden Oct-07 Germany 
012E3 0C2E G Water This study W Hann.Münden Oct-07 Germany 
012F6 0C2E G Water This study W Hann.Münden Oct-07 Germany 
406D1 0C2E G Water This study W Drakenburg Oct-07 Germany 
012F5 F429 I Water This study W Hann.Münden Oct-07 Germany 
120B4 F429 I Water This study O/A   Peine Oct-07 Germany 
055SB2 F429 I Water This study W Hess. Oldendorf Jul-08 Germany 
110SB7 F429 I Water This study O/A  Groß Schwülp. Jul-08 Germany 
114SE3 F429 I Water This study O/A  Börßum Jul-08 Germany 
114SF2 F429 I Water This study O/A  Börßum Jul-08 Germany 
120SA1 F429 I Water This study O/A   Peine Jul-08 Germany 
702SB4 EC2A J Water This study UW Langwedel Jul-08 Germany 
120SA3 F429 I Water This study O/A   Peine Jul-08 Germany 
120SB1 F429 I Water This study O/A   Peine Jul-08 Germany 
120SB3 F429 I Water This study O/A   Peine Jul-08 Germany 
120SD4 F429 I Water This study O/A   Peine Jul-08 Germany 
120SD6 F429 I Water This study O/A   Peine Jul-08 Germany 
120SE5 F429 I Water This study O/A   Peine Jul-08 Germany 
120SE8 F429 I Water This study O/A   Peine Jul-08 Germany 
W15Apr4 F429 I Water (Pirnay et al., 2005) Wlw Brussels 2001 Belgium 
PSWtB F42A I1 Water (Behar et al., 2008) unk Israel unk Israel 
110SF4 EC2A J Water This study O/A  Groß Schwülp. Jul-08 Germany 
120SF6 EC2A J Water This study O/A   Peine Jul-08 Germany 
012F4 EC29 J1 Water This study W Hann.Münden Oct-07 Germany 
514 EC2A J Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
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Strain Hexadecimal code Origin Source Additional Info Location Date Country Strain 
702F4 EC29 J1 Water This study UW Langwedel Oct-07 Germany 
706B2 EC29 J1 Water This study O/A  Celle Oct-07 Germany 
010SE1 EC29 J1 Water This study O/A  Goslar Jul-08 Germany 
012SF2 EC29 J1 Water This study W Hann. Münden Jul-08 Germany 
110C1 239A L Water This study O/A  Groß Schwülp. Oct-07 Germany 
429E2 239A L Water This study W  Ströhen Oct-07 Germany 
902E1 239A L Water This study UW Brake-Weser Oct-07 Germany 
522 239A L Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
W15Aug23 6C2A P Water (Pirnay et al., 2005) Wlw Brussels 2001 Belgium 
504 7D9A R Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
W11Aug25 6C1A S Water (Pirnay et al., 2005) Wlw Brussels 2001 Belgium 
521 6C1A S Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
496 6C1A S Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
515 6B92 S12 Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
702SF1 0D9A S19 Water This study UW Langwedel Jul-08 Germany 
924SC3 0D9A S19 Water This study UW Brake-Sieltief Jul-08 Germany 
924SD1 0D9A S19 Water This study UW Brake-Sieltief Jul-08 Germany 
924SD4 0D9A S19 Water This study UW Brake-Sieltief Jul-08 Germany 
509 3C2A U Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
924SE2 0D9A S19 Water This study UW Brake-Sieltief Jul-08 Germany 
702E3 0C1A S3 Water This study UW Langwedel Oct-07 Germany 
012SD3 2FAA S35 Water This study W Hann. Münden Jul-08 Germany 
114SB1 2FAA S35 Water This study O/A  Börßum Jul-08 Germany 
114SC2 2FAA S35 Water This study O/A  Börßum Jul-08 Germany 
110D5 4992 S5 Water This study O/A  Groß Schwülp. Oct-07 Germany 
706C4 4992 S5 Water This study O/A  Celle Oct-07 Germany 
W15Dec4 2F82 S7 Water (Pirnay et al., 2005) Wlw Brussels 2001 Belgium 
120E8 EC22 S8 Water This study O/A   Peine Oct-07 Germany 
902SB1 EC22 S8 Water This study UW Brake-Weser Jul-08 Germany 
498 4C12 T Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
500 3C2A U Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
055D5 0812 V Water This study W Hessisch Oldend. Oct-07 Germany 
055D1 0812 V Water This study W Hessisch Oldend. Oct-07 Germany 
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110A7 0812 V Water This study O/A  Groß Schwülp. Oct-07 Germany 
120F3 0812 V Water This study O/A   Peine Oct-07 Germany 
055SA2 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
055SA3 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
055SB1 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
055SB3 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
055SB4 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
055SC1 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
055SC2 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
055SC3 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
055SD4 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
055SE3 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
055SE5 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
055SF2 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
055SF3 0812 V Water This study W Hess. Oldendorf Jul-08 Germany 
429SF2 0812 V Water This study W  Ströhen Jul-08 Germany 
429SF4 0812 V Water This study W  Ströhen Jul-08 Germany 
501 0B92 X Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
429SF5 0812 V Water This study W  Ströhen Jul-08 Germany 
429SA1 0812 V Water This study W  Ströhen Jul-08 Germany 
429SD1 0812 V Water This study W  Ströhen Jul-08 Germany 
429SD2 0812 V Water This study W  Ströhen Jul-08 Germany 
429SE1 0812 V Water This study W  Ströhen Jul-08 Germany 
429SE2 0812 V Water This study W  Ströhen Jul-08 Germany 
429SE3 0812 V Water This study W  Ströhen Jul-08 Germany 
429SE4 0812 V Water This study W  Ströhen Jul-08 Germany 
429SE5 0812 V Water This study W  Ströhen Jul-08 Germany 
429SF3 0812 V Water This study W  Ströhen Jul-08 Germany 
924SA2 0812 V Water This study UW Brake-Sieltief Jul-08 Germany 
924SB2 0812 V Water This study UW Brake-Sieltief Jul-08 Germany 
924SD3 0812 V Water This study UW Brake-Sieltief Jul-08 Germany 
A 5670 7D9A R Wound (Wiehlmann et al., 2007) unk Heidelberg 1992 Germany 
502 0B92 X Water Khan (Mutharia et al., 1982) unk Japan bef. 1974 Japan 
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AL 5846 D429 Q Wound (Wiehlmann et al., 2007) unk Heidelberg 1992 Germany 
ATCC 15691 7D9A R Wound (Wiehlmann et al., 2007) unk Melbourne 1952 Australia 
PAO 0002 W Wound (Wiehlmann et al., 2007) DSM1707 unk unk unk 
 
Unk – unknown 
CF – cystic fibrosis  
G. c. aquifer - Gasoline-contaminated aquifer 
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Supplemental Table 3. Overview of the characteristics and test results of P. aeruginosa. Susceptibility - susceptebility phenpotype to lytic 
phage attack 
Motility Susceptibility  Strain (see Supplemental 
Table 2) Swimming Swarming Twitching 
Proteolytic 
activity 
Pyocyanin 
production 4 5 3 24 25 28 26 Serotype Biovolume [µm3] 
4 n n n m s 0 sl sl 0 0 sl 0 N/A 4296484.426 
11 n n n m s cl cl sl 0 cl sl sl 1 7949162.619 
12 n n n m n 0 sl sl 0 0 0 0 P/V 13574296.6 
14 nm n n m n cl cl sl 0 cl sl sl 6 5725180.53 
21 n n n n.a. n 0 0 sl 0 cl cl cl 11 12081273.42 
36 n n n m n cl cl cl 0 cl sl sl 6 12775769.86 
54 m m m n.a. n 0 0 0 0 0 0 0 P/V 9964013.056 
56 m n m m n cl cl sl 0 cl cl cl P/V 11223502.07 
69 nm n n n n 0 cl cl sl cl cl cl N/A 9309557.77 
70 n n n m s cl cl cl cl cl sl sl 1 6131314.704 
125 m m m m n cl cl sl 0 0 0 0 5 7011026.389 
126 n n n m n 0 0 cl 0 cl cl cl 11 11931688.73 
128 n n n m i sl cl 0 0 cl cl sl 1 5266131.1 
247 n n n m n cl cl cl 0 cl sl sl 1 15575713.7 
252 nm m n m n cl cl 0 sl cl cl sl P/V 13327767.79 
265 nm m n m n sl cl cl 0 0 cl 0 16 7610145.731 
278 m m m n.a. n cl cl cl cl cl cl sl P/V 15835401.18 
321 n n n m n cl cl sl 0 sl sl 0 6 11241853.85 
323 n n n m n 0 0 cl 0 sl cl 0 11 7767239.503 
345 n n n m s sl cl cl sl sl sl sl 6 9109711.681 
362 nm m m m s cl cl sl 0 0 0 0 5 8877349.326 
404 m n n n n 0 0 0 0 0 0 0 P/V 14476458.44 
424 n n n n n cl cl sl cl 0 0 0 16 13004330.25 
433 m m m m n sl cl sl 0 sl sl 0 P/V 12272312.16 
483 m m m n.a. n 0 sl 0 sl cl cl cl N/A 14873475.02 
892 n m m m i 0 cl 0 sl sl sl 0 4 6128064.066 
63741 n n n n n 0 0 0 0 0 0 0 P/V 9304042.553 
172-5645 nm m m n.a. n cl cl cl 0 cl cl sl 3 11285564.56 
188-5064 n n m n n cl cl cl sl cl cl sl 6 10139095.01 
195-5050 n n n n i sl cl sl cl 0 0 sl P/V 10146025.1 
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Motility Susceptibility Strain (see 
Supplemental 
Table 2) Swimming Swarming Twitching 
Proteolytic 
activity 
Pyocyanin 
productio 4 5 3 24 25 28 26 Serotype Biovolume [µm3] 
212-5826 nm m m n.a. s sl 0 cl 0 0 0 0 P/V 32879838.3 
2733/92 n m m n.a. s 0 0 sl cl 0 0 0 P/V 5223955.796 
2813 A/92 m m m m i 0 0 0 0 sl sl 0 P/V 5103674.269 
491-5530 n n n m n cl cl cl cl sl 0 0 6 6815369.572 
A 5670 n m m n.a. n cl cl sl 0 sl sl 0 P/V 10998623.1 
A 5803 n n n m s 0 cl 0 sl 0 sl sl P/V 15490454.1 
AL 5846 n n m m s 0 0 0 0 0 0 0 P/V 8058366.286 
ATCC 10145 n n m m n 0 0 cl sl cl cl sl P/V 6862799.252 
ATCC 15691 m m m n.a. n cl cl cl cl cl cl 0 P/V 12798577.68 
ATCC 33348 n n n n n cl cl cl sl sl cl 0 1 7660683.772 
ATCC 33356 n n m m n 0 0 sl sl sl sl sl 10 5163956.321 
ATCC 33364 m m n m s sl 0 sl 0 0 0 0 N/A 8385265.901 
ATCC 33988 n m m n.a. n 0 cl cl 0 0 0 0 11 7988723.58 
BST 1 n m n n n cl cl cl sl cl cl sl 1 7004430.261 
CHA n n m m n cl cl cl 0 sl sl 0 6 10684477.05 
DM m m n n.a. n 0 0 0 0 sl sl 0 P/V 61874774.37 
DSM 1128 n n h m s 0 0 0 0 cl 0 0 P/V 13340709.08 
DSM 1253 m m m m n cl cl sl 0 0 0 0 P/V 33489221.35 
DSM 288 m m m n.a. n cl cl cl 0 0 0 0 P/V 16716887.38 
DSM 939 n m m m n cl cl cl sl sl sl 0 P/V 5762733.803 
G7 n n m n.a. n cl cl sl sl cl cl sl P/V 8052183.157 
Gr 2052 h h m n n cl cl cl cl cl cl sl 3 10666548.15 
Gr 2057 n n m n n cl cl cl cl cl cl sl 3 10431954.81 
Gr 2248 h m m n.a. n 0 0 0 0 0 0 0 5 9096307.984 
H2 m n m m s 0 0 cl 0 sl sl 0 4 9521392.689 
HJ2 nm m m m n cl 0 cl 0 cl cl 0 P/V 8363971.749 
K9 nm n m n.a. n sl 0 sl 0 cl cl sl P/V 4456757.698 
KB1 n m n n n cl cl cl cl 0 0 0 5 6878501.121 
LES400 nm m m n.a. n 0 0 sl sl sl sl 0 P/V 10237001.47 
MF 6 n n m n i cl cl sl cl sl sl 0 3 5548460.411 
PA14 n m n n n 0 0 0 sl 0 0 0 10 7203300.171 
PAK n m n m n sl sl 0 sl sl sl 0 6 4956002.409 
PAO n n n n n cl cl sl cl 0 0 0 16 7522665.023 
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Motility Susceptibility Strain (see 
Supplemental 
Table 2) Swimming Swarming Twitching 
Proteolytic 
activity 
Pyocyanin 
productio 4 5 3 24 25 28 26 Serotype Biovolume [µm3] 
PD 1 n n n n i cl cl cl 0 0 0 0 9 4873289.963 
RN 4 n m n n n sl sl sl cl 0 0 0 P/V 7500890.686 
RP 1 n n n n n cl 0 cl 0 cl cl 0 P/V 11845263.24 
SG1 (= C) m m m m s 0 0 cl sl 0 sl sl 10 8789967.423 
SS 1 n m m n n cl cl sl 0 sl sl sl 3 12839788.66 
TBCF10839 n n n n n 0 0 0 sl 0 0 0 P/V 14790232.98 
Va 24437 n n n m i 0 0 0 0 0 0 0 4 10058987.03 
Va 26232 h m m n.a. n 0 0 0 0 0 0 0 6 11780564.67 
Va 27081 m n n m n cl cl cl cl cl cl cl 10 9033336.498 
Va 27260 h m n n.a. n sl sl sl 0 sl sl 0 5 11424110.92 
ZW 102 n n n n i 0 0 0 0 0 0 0 10 5927929.47 
ZW 113 n m m n.a. n 0 0 sl 0 0 0 0 P/V 10666494.8 
ZW 117 n m n n n sl cl cl 0 0 0 0 5 5749278.728 
ZW 119 n m n m n 0 0 cl 0 cl cl sl 11 6244612.792 
ZW 30 n h n n n cl cl sl cl cl cl cl 3 7215073.608 
ZW 31 n n n m n cl cl sl sl cl sl sl 6 4761039.193 
ZW 41 nm m m n.a. n cl cl cl 0 0 0 0 P/V 7934053.573 
ZW 43 m n n n.a. n 0 0 cl 0 cl sl 0 10 4627478.462 
ZW 49 nm n m m n 0 cl sl cl cl cl sl P/V 44011808.71 
ZW 54 n n n n i 0 0 0 0 0 0 0 P/V 8253139.799 
ZW 64-1 n m m n.a. n 0 0 0 sl 0 0 0 1 25092342.08 
ZW 77 m n n m n 0 0 0 0 0 0 0 P/V 8316581.59 
ZW 79 nm m m m n 0 cl cl sl cl cl sl P/V 25909720.55 
ZW 81 nm m n n.a. n 0 0 sl 0 cl cl sl P/V 42066883.55 
ZW 83 n m m m n 0 cl 0 0 cl cl sl 3 14438270.85 
ZW 85 n m n n i 0 0 cl sl cl cl cl 10 24980792.81 
ZW 88 m h m n.a. n 0 0 0 0 0 0 0 7 27388081.27 
ZW 92 n n n m n 0 cl cl cl cl cl cl P/V 8601681.354 
ZW 98a nm m m n.a. n 0 sl 0 0 cl cl 0 P/V 13357752.7 
110E8 m n n n n 0 0 0 cl cl cl cl 10 22142222.69 
406E1 n n n n n 0 sl sl cl cl cl cl 3 15870434.96 
702E1 n n n n n 0 sl sl cl sl sl 0 1 12311177.55 
120E2 nm m n n n 0 0 0 0 0 0 0 7,8 6223119.057 
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Motility Susceptibility Strain (see 
Supplemental 
Table 2) Swimming Swarming Twitching 
Proteolytic 
activity 
Pyocyanin 
productio 4 5 3 24 25 28 26 Serotype Biovolume [µm3] 
429E4 n n n n.a. n 0 0 0 cl cl cl cl 3 4042693.547 
012E6 n n n n.a. s cl cl sl sl 0 0 0 2 12696831.71 
429E5 nm m m n.a. n cl cl sl cl 0 0 0 6 5450109.332 
055E6 nm m m m n sl 0 cl 0 0 0 0 7,8 11048671.07 
110E6 n m n n n 0 0 0 0 cl sl cl 9 13230473.9 
055E7 n n n n n sl cl cl cl sl sl sl 6 7667534.814 
110E7 n m n n.a. s 0 0 sl 0 0 0 0 11 8350686.617 
120E9 n m n n n 0 sl sl 0 cl sl cl 11 10310843.33 
055E11 n n n n n sl cl cl cl sl sl sl 6 8631830.285 
010SB1 n n n n n sl sl sl sl sl sl sl 1 9744937.81 
012A2 nm n n n n sl sl sl sl sl sl sl 3 7077114.141 
012B2 n n n n n cl cl cl 0 0 sl 0 6 12395279.17 
012B5 n m n m s 0 0 0 0 0 0 0 6 17393356.1 
012D3 n n n n n cl cl cl sl 0 0 0 9 11749969.14 
012SC1 n n n n n cl cl cl cl 0 0 0 16 9749710.024 
012SC3 n n n n i cl cl cl 0 0 0 0 6 13225482.35 
012SD1 n n n n n cl cl cl 0 0 0 0 1 12464941.64 
012SE1 m m n m n cl cl cl cl cl 0 0 6 12025398.01 
012SF1 n n n n n cl cl sl sl sl sl sl 6 11058110.77 
055C1 n m m m i cl cl cl 0 0 0 0 5 7548527.854 
055F1 nm m n n.a. s 0 0 0 0 0 0 0 4 11076144.4 
055SD1 n n n n n cl cl cl 0 sl sl 0 1 8751032.876 
055SD3 n n n n n 0 0 0 cl 0 0 0 13 9355135.871 
055SE2 n n n n n cl cl cl sl sl cl sl 1 13012447.95 
055SE4 n n n n n cl cl cl cl sl sl 0 6 8728604.459 
110B13 m m n m n 0 sl sl sl sl sl sl 1 6529599.92 
110B14 nm m m n.a. n 0 cl 0 cl sl sl sl 6 14230957.18 
110B2 nm m n n.a. n 0 0 0 0 0 0 0 4 12894822.27 
110D1 n n n n n 0 0 0 0 0 sl 0 8 9062133.795 
110F3 n n n m s cl cl cl 0 0 0 0 9 7211494.941 
110SA1 n n n n n cl cl cl cl sl sl sl 6 15418390.7 
110SA2 n n n n n cl cl cl sl 0 0 0 9 9040304.128 
110SA3 n n n n n cl cl sl sl sl sl sl 6 10441930.02 
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Motility Susceptibility Strain (see 
Supplemental 
Table 2) Swimming Swarming Twitching 
Proteolytic 
activity 
Pyocyanin 
productio 4 5 3 24 25 28 26 Serotype Biovolume [µm3] 
110SB3 n n n n n cl cl cl 0 sl sl sl 6 12083994.48 
110SB4 n n n n n 0 sl sl sl sl 0 0 1 10112099.89 
110SB6 n n n m s 0 sl 0 0 0 0 0 6 6558733.149 
110SC1 n m m m n 0 0 sl 0 sl sl sl 7 8280142.823 
110SD4 n n n n n 0 0 cl 0 sl sl 0 7 11443259.06 
110SE2 n n n n n cl cl cl sl sl sl sl 6 11417655.09 
110SF5 n n n n n cl cl 0 cl 0 sl 0 1 9545111.481 
114A2 n n m m n cl cl cl cl 0 0 0 9 11167389.53 
114SA7 n n n n n sl sl sl sl sl sl sl 6 12504704.16 
114SB3 n h n i n 0 0 0 0 0 0 0 N/A 6092621.238 
114SB4 n n n m s sl sl sl 0 0 0 0 1 8244620.952 
114SC1 n n n n n 0 0 0 0 0 0 0 4 14408483.54 
114SE1 n n n n n 0 0 0 0 0 0 0 6 15468837.85 
120A1 nm n n m i 0 0 0 cl sl sl 0 6 9784631.168 
120B3 nm n n n n 0 0 sl cl 0 0 0 4 8669938.833 
120B5 n n n n n cl cl sl 0 0 0 0 N/A 9203909.057 
120D11 nm n n n n cl cl cl 0 sl sl sl 6 9541896.412 
120D6 n n n m i cl cl 0 0 sl sl 0 6 11062201.24 
120D8 nm n m m i cl cl sl sl sl sl sl 6 11971619.21 
120F4 n n n n n cl cl cl cl 0 0 0 16 9465665.482 
120SA2 n n n n n cl cl cl sl 0 sl 0 1 8624921.937 
120SB2 n n n n n 0 sl sl sl sl sl sl 1 11376503.39 
120SC3 n n n n n 0 sl 0 sl sl sl sl 6 11303679.21 
120SD1 n n n n n 0 0 0 sl 0 0 0 4 12291952.34 
120SD2 n n n n n cl cl 0 0 sl sl 0 6 10584657.75 
120SD3 n n n n n 0 sl 0 0 sl sl sl 3 10481813.08 
120SE2 n n n n n cl cl cl 0 sl sl 0 6 15052281.87 
120SE7 n n n n n cl cl cl 0 sl sl sl 6 12916653.91 
120SF3 m n n n n cl cl sl sl sl sl sl 6 9357455.78 
120SF5 n n n m n cl cl cl 0 0 0 0 1 11791946.84 
120SF7 n n n m i cl cl cl 0 sl sl sl N/A 6727863.176 
401F1 n n n n n 0 sl sl 0 0 0 0 13 8934876.734 
406A2 n n n n n cl cl cl sl sl cl cl 3 11362066.21 
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Motility Susceptibility Strain (see 
Supplemental 
Table 2) Swimming Swarming Twitching 
Proteolytic 
activity 
Pyocyanin 
productio 4 5 3 24 25 28 26 Serotype Biovolume [µm3] 
406B1 n n m m n cl cl 0 sl sl sl 0 6 13417307.56 
406C1 n n m n n 0 sl 0 0 sl sl 0 1 7941823.488 
406SF1 n n n n n cl cl cl cl 0 0 0 N/A 6606565.948 
429A2 n n n n n 0 0 sl 0 cl sl sl 11 13341284.12 
429C1 n n n n n cl cl 0 sl 0 0 0 3 11217678.58 
429C2 n n n m i 0 0 0 0 cl sl 0 16 9384118.919 
429C4 n m n n n cl cl cl 0 cl 0 cl 6 11374920.56 
429D2 n n n n n 0 sl 0 sl 0 sl 0 7,8 4930902.342 
429SC1 n n n n n sl cl sl 0 sl sl 0 5 5784304.604 
702D4 n n n n n 0 0 0 0 0 0 0 6 10565151.94 
702F3 n n n n n 0 0 sl sl 0 0 0 10 9896405.705 
702SC1 nm n m m n 0 0 0 0 0 0 0 7 5270442.889 
702SD3 n n n n n 0 0 sl 0 0 0 0 6 14455355.97 
702SE1 n n n n n cl cl cl sl sl sl sl 6 12625959.89 
702SF2 n n n n n 0 sl sl 0 sl sl 0 6 11999649.79 
706B1 n m n n n cl cl cl cl sl sl sl 6 10102227.44 
706D1 n n m n n cl cl cl cl sl sl 0 6 11106864.42 
706SA2 n n n n n sl cl 0 0 0 sl 0 6 7406805.946 
706SC3 nm m m m n 0 0 0 0 0 0 0 4 18341354.91 
902C1 m m n m n 0 0 sl 0 0 0 0 6 9125826.548 
902F1 n n n m i 0 0 0 0 0 0 0 N/A 4942543.382 
902SA4 m n n n n cl cl cl 0 0 0 0 16 11355171.7 
902SB4 n n n n n 0 sl sl 0 0 0 0 N/A 11350097.14 
902SD3 n n n n n 0 sl 0 cl sl cl cl 3 11089395.94 
902SE1 n n n n n 0 sl sl sl sl sl sl 1 9609800.174 
924SB3 n n n n n sl cl sl sl sl sl sl 1 11034579.7 
924SE1 n n n m n 0 0 0 0 0 0 0 4 13217736.14 
924SE4 n n n n n 0 sl sl sl 0 0 0 9 11623413.59 
924SF5 n n n n n cl cl cl sl sl 0 0 9 8827400.154 
Motility. Swimming: nm – “non motile”; m – “minimal”; n – “normal”; h – “hyper”. Swarming: m - “minimal”; n - “normal”; h - “hyper”. Twitching:  
m - ”minimal”; n - “normal”; h - “hyper”. Proteolytic activity: n.a. - ”no activity”; m - “minimal”; n - “normal”; i - “increased” activity. Pyocyanin 
production: n -  “normal”, i - “increased”, s - “strong” production. Phages susceptibility: 0 - no lysis; sl - semilysis; cl - clear lysis. 
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